Trading for the Masses

19:15 CLZR Candela Earnings Color (7.28 -0.11) -Update-

Reuters Estimates is telling us that an actual of $0.01 per share is comparable to Reuters estimates of $0.01. See earlier comment at 16:36.
19:11 SBCF Seacoast Banking misses by $0.01 (14.28 -0.32)

Reports Q3 (Sep) earnings of $0.01 per share, $0.01 worse than the Reuters Estimates consensus of $0.02.
19:03 After Hours Summary: AMZN down 9.2% on earnings/guidance; GSS down 6.3% (proposed offering of convertible senior unsecured debentures and preannounces Q3 results)

Companies moving in after hours trading in reaction to earnings: Trading Up: PFWD +7.1%; ACE +4.3%; CEPH +2.7%; STKR +2.4%; CTX +2.3%; CAKE +1.9%… Trading Down: RVBD -22.4%; ANAD -19.8%; EFII -17.5%; CTHR -14.9%; BRCM -12.3%; ALTR -12.1%; SVVS -11.6%; WIRE -11.5%; TRMB -10.6%; SUPX -9.7%; AMZN -9.2%; INFN -9.0%; PNRA -8.8%; JNPR -7.1%; BTUI -6.5%; RFMD -6.4%; ILMN -6.2%; SSTI -5.7%; PLT -5.2%; EPIC -4.2%; HLIT -3.6%; VOCS -3.2%; CLMS -3.0%; NARA -2.7%; DDUP -2.2%; HOKU -2.2%; SEAB -2.1%; CHRW -2.1%; NBR -1.9%; CLZR -1.8%; BCR -1.8%; YDNT -1.4%; FLEX -1.4%; ACTL -1.3%; AFL -1.2%; ORLY -1.2%; CNW -1.1%; CB -1.0%; PTP -1.0%… Trading Up: JEC +3.5% (to replace Avaya in S&P 500); CF +3.3% (to replace Jacobs Engineering in MidCap 400 ); CTX +2.2% (CEO says co is “meaningfully reducing prices” in response to market conditions)… Trading Down: GSS -6.3% (proposed offering of convertible senior unsecured debentures and preannounces Q3 results); KOSN -2.3% (presents phase 1 data showing antitumor activity and safety profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting); DDUP -2.2% (announces intent to file registration statement for underwritten common stock offering); IPAR -2.1% (reports Q3 revs slightly below consensus; issues FY07 guidance slightly below consensus); WSCI -2.1% (reports AugQ revs up 21%, no estimates); CEO -1.8% (CNOOC CFO: Not interested in US Gulf Energy assets — DJ); SRI -1.8% (announces Brazilian joint venture IPO filing); MATK -1.8% (wins German DHA patent infringement actions against Lonza and one of Nutrinova’s customers); ISSI -1.5% (board authorizes $30 mln share repurchase program); EXEL -1.4% (Updated phase 1 data for Exelixis’ XL184 demonstrate Pharmacodynamic and clinical anti-tumor activity); NOVN -1.3% (FDA issues approvable letter for Stavzor delayed release Valproic acid capsules); VHI -1.1% (announces radioactive byproduct license decision).
19:01 CME CME Group and the Brazilian Mercantile & Futures Exchange agree to cross-equity stakes and exclusive order routing deal (634.60 +15.90) -Update-

Co and the Brazilian Mercantile & Futures Exchange S.A. (BM&F), the world’s fourth largest derivatives exchange and the largest derivatives exchange in Latin America, announced that they have signed a non-binding letter of intent covering a proposed cross-investment between them. Under the arrangement, CME Group will acquire an equity stake of ~10%in BM&F in exchange for an equity stake of approxima~ 2% in CME Group. The transaction is expected to be completed following the close of BM&F’s initial public offering, which is expected to occur this year.
18:52 BOFL Bancshares Of Florida reports in-line (15.11 +0.30)

Reports Q3 (Sept) earnings of $0.12 per share, in-line with the Reuters dual-analyst est of $0.12.
18:41 ANCX Access Natl misses by $0.11 (7.00 +0.05)

Reports Q3 (Sept) earnings of $0.02 per share, $0.11 worse than the Reuters single-analyst est of $0.13.
18:38 DD DuPont Announces 11 Percent Dividend Increase TO $0.41 from $0.37 -Update-

18:33 SHEN Shenandoah Telecom beats by $0.01 (24.24 +0.15)

Reports Q3 (Sept) earnings of $0.22 per share, $0.01 better than the Reuters Estimates consensus of $0.21; revenues fell 16.8% year/year to $35.4 mln vs the 35.9 mln consensus
18:31 ORLY O’Reilly Auto reports EPS in-line, revs in-line (33.22 +0.33)

Reports Q3 (Sep) earnings of $0.46 per share, in-line with the Reuters Estimates consensus of $0.46; revenues rose 10.8% year/year to $661.8 mln vs the $662.1 mln consensus.
18:23 VHI Valhi announces radioactive byproduct license decision (24.7 +1.55)

Co that its wholly owned subsidiary, Waste Control Specialists LLC (”WCS”), received notification that the Executive Director of the Texas Commission on Environmental Quality (”TCEQ”) has prepared a draft license and made a preliminary decision that this license meets all statutory and regulatory requirements for the disposal of byproduct material at WCS’ site in Andrews County, Texas. Byproduct material includes uranium or thorium mill tailings as well as equipment, pipe and other materials used to handle and process the mill tailings.
18:20 GHS GateHouse Media to acquire publications from Morris for $115 mln (11.25 -0.15)

Co announced that it has signed a definitive asset purchase agreement to acquire several daily and non-daily publications from Morris Publishing Group for a purchase price of $115 mln. The transaction is expected to close before the end of November and is subject to regulatory approval and customary closing conditions.
18:17 AMZN Amazon.com Conference Call Summary (100.82 +9.53) -Update-

Says electronics and toys & babies had a good quarter… had an operating margin of 4.0% compared to 4.8% in prior quarter, Y06 was approx 3.4%… gross margin increased 80 basis points to 20.5%… says guidance is appopriately conservative as their is uncertainty with consumer demand and foreign exchange rates for Q4… Bigger base will allow co to make investments without effecting the rest of the co… co says they have greatly improved inventory management… co says Harry Potter had an effect on margins… co says not giving guidance on individual line items but appears to believe that margins return back to normal after the Harry Potter phenomenon passes… says they like the geographies that they are in… says happy with early results for the MP3s; says so far has been successful but have a lot of areas that they need to improve; have not seen any evidence of MP3s cannibalizing there DVD sales, says it is too early to figure out the effetc if any…. Co says this was their best quarter ‘by far’ in the toy category; looking forward to the Xmas holiday… says have been successful signing up Prime members… co had a large ramp up in the fulfillment area ahead of the holiday season… says Japan has been solid in early returns… excited about grocery area but still tooeary to say… says do not have any comments on the Borders contract… says will see Harry Potter sales in Q4 but it will not be as sizeable as in Q3… majority of prime marketing is being done on their web site… call has ended.
18:08 MKTIN Market Internals -Update-

The Dow was up 0.81% at 13676, the Nasdaq was up 1.65% to close at 2799, and the S&P was up 0.88% to close at 1520. Leading sectors included: Education +9.9%, Internet Retail +7.0%, Real Estate Management +4.7%, Diversified Metals and Mining +4.1%, Oil and Gas Equip +3.1%. Lagging sectors included: Forest Products –2.8%, Diversified Metals and Mining –2.7%, Tires and Rubber –2.6%, Oil and Gas Equip –1.7%, Electronic Equip Manu –1.5%. Today’s movement came from lower than avg volume on the NYSE, and higher than avg on the Nasdaq (NYSE 1312, vs. 1576 avg, Nasdaq 2390, vs. 2074 avg), with advancers outpacing decliners (NYSE 2263/1059, Nasdaq 1807/114 with new lows outpacing new highs and new highs outpacing new lows (NYSE 78/98; Nasdaq 118/115).
18:05 CYMI Cymer Earnings Call Summary (42.23 +0.9 -Update-

On the call, the co says that they anticipate demand will remain strong for the remainder of the year, with NAND retaining its strength. Co is expecting NAND strength into next year. Co states that ASML signed a new multi-year agreement with the co for L.P.P., which they believe is a major endorsement of their technology. The co reported gross margins of 50%, and they are projecting approx 50% margins for next year. Co says they are very comfortable holding that range going forward as a model. Aggressive pricing and cost of goods sold associated with producing larger versions of immersion, including a larger sales force servicing onsource contracts, will weigh on margins going forward. Co says they have a renewed vigor with the crypton layer of business, seeing very high demand. In terms of the co’s share buyback, the co has spent $288 mln of its $300 available share repurchase authorization. Co says order flow for X.L.R has begun, with shipments commencing this qtr. The co is anticipating growing orders for X.L.R for this qtr and next. The co anticipates a 3% increase in R&D over Q2 level to meet rising demand from customers of new technology, and anticipates SG&A to be in the $17-17.5 mln range.
18:02 JNPR Juniper Networks conference call summary (37.14 +1.25) -Update-

Have seen steady demand, with book-to-bill greater than 1. Have seen strength in all geographies compared to a year ago. With this qtr’s MX960 sales, now at a $100 mln run rate after only 2 qtrs… Raises Q4 guidance, sees EPS $0.24 vs $0.23 consensus; sees revs $770-790 mln vs $751.3 mln consensus… Gross margins positively impacted by product mix and richer configuration. Customers saw a need for higher port count and speed per port. SSG was up 20% sequentially. SLT margins came down, since expenses were higher than planned. Integrated products are growing at higher rates than point products. SLT product line came in light of expectations at 17% growth rate, due to seasonality & lumpiness — but was very small difference between expectations and actual rev. Regarding operating margins tgt of 25%, committed to sustained improvement in op margins towards 25%; when co reaches 25%, will see what they can do to improve from there. Not much new to report on competitive front… Despite SLT shortfall, co emphasizes that it still grew faster than mkt… Stock is trading down at ~34.70 after-hours.
18:00 BRCM Broadcom Conf Call Summary… stock trading at $36.63 in after hours, initially weaker on disappointing EPS & taking another leg lower following rev guidance (42.06 +0.36) -Update-

On call, co guides Q4 product revs to $960-990 mln (consensus $986.56); however, this does not include any revs associated with patent license signed with VZ in July. With respect to the Verizon royalty, expects to receive info from VZ at end of this month detailing how many phones received the $6 royalty. BRCM indicates it will possibly update this info at its Analyst Day. Co reits that its gross margin guidance does not include the positive impact of VZ deal… Co says feels it is fair to beat them up on R&D as it is running above where co projected. However, co believes this a situation where it is experiencing design wins — which forces them to go out and higher people. Wants to invest in long-term value for the shareholder; believes when you get these opptys — you have to go for them. Pts out can’t share all of the design wins (i.e., customer name), but hopes to be able to provide more color over time.
17:59 BRP Brasil Telecom announces gross revenue of R$ 4.0 bln and EBITDA of R$ 970.1 mln in 3Q07 (73.90 +0.81)

Co registered consolidated EBITDA of R$970.1 mln in 3Q07, 6.8% higher than in 3Q06. Consolidated EBITDA margin stood at 35.3%. Consolidated net revenue reached R$2,748.3 million, 4.6% higher than in 3Q06, and net income amounted to R$150.3 million, 134.7% up on 3Q06. Mobile telephony EBITDA totaled R$34.0 million in 3Q07, an increase of R$54.3 million over the same period the previous year, while the EBITDA margin came to 7.6%, 13.3 p.p. higher than in 3Q06.
17:58 CAKE Cheesecake Factory Earnings Conference Call Summary (23.30 -0.44) -Update-

On their conference call co notes their longer term expectations remains in the range of menu price increases or 1-2%. For 2007, co’s overall revenue growth target is 15-16%. Which translates into 15% growth in the 4th quarter. This is a little bit lower than our previous guidance and reflects the softer sales they experienced in the second half of September and the first couple weeks of October. Overall comparable calls are tracking between flat and a positive 1%. Co is on target to achieve our goal of opening as many as 21 new restaurants including five Grand Lux Cafe. Based on co’s current outlook for warehouse club sales they expect bakery sales to be approximately flat to down 1% in fiscal 2007 compared to the prior year. Co is targeting revenue growth of 14-15% not much different than for the last few years, net income growth of 18-19%. Co’s plan consists of three key objectives, expand their restaurant base at a rate that is healthy for our business. Two use their free cash flow to return cash to stockholders and improve our operating margin by 30 to 50 basis points. Co’s plan is to open 17 new restaurants and as much as three to four Grand Lux Cafe and one Rock Sugar Pan Asian Kitchen, their newest concept. The 2008 plan targets four fewer restaurants than in 2007. Co doesn’t believe they will be changing their pricing strategy. In Q&A co notes that as of now, both staff members and stores are impacted by fires in California. In 2008, co is assuming flat labor and commodity costs.
17:57 PNRA Panera Bread beats by $0.01, reports revs in-line; guides Q4 EPS in-line (48.81 +1.61)

Reports Q3 (Sep) earnings of $0.37 per share, $0.01 better than the Reuters Estimates consensus of $0.36; revenues rose 33.3% year/year to $273.2 mln vs the $275.2 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.53-0.59 vs. $0.60 consensus. PNRA notes Initial target for fiscal 2008 diluted EPS growth established at 10% to 20%. Co notes the Q4 2007 target assumes system-wide comparable bakery-cafe sales growth of 1.0% to 3.5% (including the price increase of ~2.5% which the Co will be taking on November 14, 2007) and system-wide average weekly sales of $39,700 to $40,700. Co says, “Despite operating in a very uncertain consumer and cost environment, our concept remains strong as evidenced by our industry leading customer satisfaction ratings, high unit volumes and resulting strong bakery-cafe return on investment. These factors speak to our potential for future growth.”
17:56 CLMS Calamos Asset: Conference Call Summary (31.96 +0.83) -Update-

On call co notes that assets under mgmt were $46.7 bln - the highest level since May 2006. Says financial position remains highly liquid… During Q&A co says they’re portfolio wasn’t impacted by subprime. Says they are looking at areas that might be opportunistic in the current mkt. Notes there is a nervousness in the mkt, and some closed-end funds are trading at a discount to NAV, despite having no impact from subprime.
17:55 CLZR Candela earnings call summary (7.28 -0.11) -Update-

The co announces that its sales force expansion is on target. No new updates on litigation. This Q is generally the weakest for the industry. Regarding gross margin being lower than expected, that is directly related to a lower volume. An analyst asked a question wondering if there is a slowdown, the co does not see one yet. Mgmt also noted that to some degree, the business is recession-proof. As an example, when Japan had their 10-yr recession, it did not effect CLZR. Mgmt does not think a slowdown will affect its business.
17:53 FMP Feldman Mall Properties announces modest delay in reporting Q2 2007 financial results (5.17 -0.05)

Co reported that it is in the final stages of completing the release of its Q2 2007 financial results and plans to release earnings for Q2 within the next few days. Following the release of Q2 earnings, the Company will schedule a conference call to discuss Q2 results.
17:53 CASB Cascade Financial reports in-line (15.57 +0.07)

Reports Q3 (Sept) earnings of $0.31 per share, in-line with the Reuters Estimates consensus of $0.31.
17:51 BCR C.R. Bard: Conference call summary (86.38 +0.76) -Update-

Co says on the business development front, after closing the Ultraclip and Permasorb transactions in Q2 they did not complete any deals this quarter. However, they are actively pursuing a number of deals that could potentially close in Q4. Co says the much larger synthetic hernia line experienced a slight decline for the period, resulting in a net decline for the core hernia category. They believe growth will be challenging until their internal pipeline of differentiated products begin the launch in the back half of next year. Co says their rev issues in hernia are driving an unfavorable mix in gross profit, which is making it difficult to show improvement. For 4Q07 the co is expecting constant currency revenue growth between 8 and 9% for the coming quarter. Their surgery business will continue to face supply issues in the qtr. Co their international businesses are currently running a little bit soft. Co says in their surgical business, the restored clinical trial for the treatment of parents with after gastric bypass surgery continue enrollment with 10 active centers. Co says their enrollment is slower than expected, and they’re evaluating options for improving patient recruitment. Their original plan was to enroll through mid-2008, but says enrollment may take a few quarters longer than expected. When asked about oncology the co they had some particularly tough comps in prior years based on the launches of a number of products within the oncology space. Co says they have one major new product launch in Q4, the valve PICC Solo which they think has a very unique position in a great space. Co says they were probably slightly behind their plan in biologics, but, not substantially.
17:51 BUSE First Busey Corp reports in-line (20.54 -1.00)

Reports Q3 (Sept) earnings of $0.36 per share, in-line with the Reuters single-analyst est of $0.36.
17:51 SWC Stillwater Mining releases 2007 Q3 production results; heavily affected by the labor issues there early in the quarter. (10.81 +0.36)

Co releases preliminary third quarter and year-to-date production results for its two operating mines and volumes processed in its platinum-group metal recycling activities. As anticipated, the results indicate that third quarter production at the Stillwater Mine was heavily affected by the labor issues there early in the quarter. Mine production for the third quarter and first nine months of 2007 overall was weaker than in the corresponding periods of 2006, particularly at the Stillwater Mine. Issues affecting third quarter 2007 output included a seven-day strike and associated labor disruption during July, and lower average productivity as the percentage of new miners in the workforce has increased. In addition to these third-quarter issues, the nine-month year-to-date results during 2007 also have included challenges with the performance of some new LHD equipment and lower productivity at the Stillwater Mine during the labor negotiations that led up to the strike. East Boulder Mine production during the quarter, which was unaffected by the labor issues, increased slightly from the year earlier results.
17:50 PNRA notes Initial target for fiscal 2008 diluted EPS growth established at 10% to 20%

17:49 PNRA sees Q4 $0.53-0.59 vs $0.60 Reuters consensus

17:49 PNRA prelim $0.37 vs $0.36 Reuters consensus; revs $273.2 mln vs $275.19 mln Reuters consensus

17:48 RJET Republic Airways misses by $0.01, misses on revs (20.44 -0.01)

Reports Q3 (Sep) earnings of $0.49 per share, excluding non-recurring items, $0.01 worse than the Reuters Estimates consensus of $0.50; revenues rose 7.8% year/year to $330.1 mln vs the $353.4 mln consensus. The co expects to take delivery of 7 new E175s in the fourth quarter of 2007 and 27 new E175s during 2008. Additionally, 3 new E175s are scheduled for delivery in the first quarter of 2009. The co has firm financing commitments in place for 28 of its 37 remaining firm aircraft at competitive interest rates. The co expects to obtain competitive financing commitments on its remaining firm aircraft.
17:46 YDNT Young Innovations misses by $0.01 (25.64 -0.4

Reports Q3 (Sept) earnings of $0.39 per share, excluding $0.04 charge, $0.01 worse than the Reuters Estimates consensus of $0.40; revenues rose 3.5% year/year to $24.7 mln vs the $25.5 mln consensus.
17:46 RVBD Riverbed Technology Guiding Q4 EPS at approx $0.19 vs $0.19 consensus -Update-

17:46 RVBD Riverbed Technology Guiding Q4 revs $69-71 mln vs $69.2 mln consensus -Update-

17:45 NOVN Noven Pharma: FDA issues approvable letter for Stavzor delayed release Valproic acid capsules (14.17 +0.10)

“The FDA states in the letter that it has completed its review of the Stavzor NDA and that it is approvable. The FDA has requested certain non-clinical information, including additional in vitro dissolution data, as a condition to final approval. The FDA has not requested additional human studies or clinical data. Because the NDA for Stavzor, submitted under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act, references Abbott Laboratories’ Depakote product, final approval is also subject to the expiration of any applicable exclusivity periods benefiting Depakote. Based on receipt of the approvable letter, interaction with Banner Pharmacaps (the NDA holder and developer of the product), and its understanding of Depakote exclusivity, Noven continues to expect Stavzor final approval, at the latest, by the end of July 2008. We are now working with Banner to satisfy the conditions to final approval as expeditiously as possible. Banner has advised that it expects to respond to the FDA’s requests in the coming weeks. Concurrently, the Noven/JDS team has begun launch and production planning in anticipation of a 2008 launch of Stavzor.”
17:43 RJET prelim $0.49 vs $0.50 Reuters consensus, $0.51 First Call; revs $330.1 mln vs $353.38 mln Reuters consensus, $346.00 mln First Call

17:42 DDUP Data Domain beats by $0.02 (40.39 +1.44) -Update-

Reports Q3 (Sept) earnings of $0.04 per share, $0.02 better than the Reuters Estimates consensus of $0.02; revenues rose 21.0% year/year to $32.0 mln vs the $30.0 mln consensus
17:42 CHRW C.H. Robinson: Conf call summary (51.84 -1.24) -Update-

Continue to be challenged to reach goals for the top line gross revenues and net revenues. Continue to focus cross-selling and account mgmt with customers to offer intermodal choices where appropriate. Says freight demand continued softening in the co’s core North American market… Call moves into Q&A… Co says it feels like the market softening and freight demand softening is very similar to previous periods like 01 and 02. From the standpoint of how they’ve managed transportation for the last three or four decades and kind of the normal fluctuations in supply and demand, this feels like in a lot of ways just a typical softening of the demand side. Co says they don’t know how long this will last, but says market has continually cycled up and down from a supply and demand standpoint. In past downturns the co says they have never had trouble finding capacity. Says hard to say what Q4 is going to feel like. Continuing to look at acquisitions, nothing imminent or specific to discuss. Says they are looking for other third party logistics businesses that could help build out network and offer new services. Co says no shift in hiring trends during the slow period. Co says one specific example that has had a meaningful impact on the trucking environment is the Canadian situation with regards to the Canadian Dollar being now worth more than a U.S. Dollar.
17:40 ARTW Art’s-Way Manufacturing appoints Carrie Majeski as President and CEO (21.46 +0.15)

17:39 MDP Meredith announces multi-year agreement with Wal-Mart for creation of Better Homes and Gardens home products (56.70 +0.50)

Co announces a multi-year licensing agreement with Wal-Mart Stores (WMT) for the design, marketing and retailing of a wide range of home products based on the Better Homes and Gardens brand. This new line of home products is expected to be available exclusively in Wal-Mart stores by the fall of 2008.
17:39 CTS CTS Corp misses by $0.01; guides FY07 EPS below consensus (13.45 -0.07)

Reports Q3 (Sept) earnings of $0.21 per share, $0.01 worse than the Reuters Estimates consensus of $0.22; revenues rose 6.0% year/year to $174.8 mln vs the $173.2 mln consensus. Co issues downside guidance; sees FY07 EPS of $0.67-0.70, excl $0.02 charge, vs $0.72 Reuters consensus. Co also notes they expect Q4 EPS to be similar to Q3. Co says, “Looking forward, we continue to expect sales growth from new products, new customers and tuck-in acquisitions. Earnings in 2008 are further expected to benefit from the fact that certain unusual costs such as the Moorpark investigation, CEO transition and Czech Republic start-up, which adversely affected 2007 earnings by ~$0.10, will be behind us.
17:35 FRH Freedom Acquisition announces expected transfer of listeing to NYSE under the symbol GLG (13.31 +0.31)

17:32 WMK Weis Markets reports Q2 EPS of $0.40 vs $0.43 yr ago; revs rose 1.4% to $565 mln YoY (42.61 +0.31)

17:30 CAKE Cheesecake Factory Conference Call Update III (23.30 -0.44) -Update-

Co is targeting revenue growth of 14-15% not much different than for the last few years, net income growth of 18-19%. Co’s plan consists of three key objectives, expand their restaurant base at a rate that is healthy for our business. Two use their free cash flow to return cash to stockholders and improve our operating margin by 30 to 50 basis points. Co’s plan is to open 17 new restaurants and as much as three to four Grand Lux Cafe and one Rock Sugar Pan Asian Kitchen, their newest concept. The 2008 plan targets four fewer restaurants than in 2007.
17:27 BCR C.R. Bard sees Q4 EPS of $0.98-0.99 vs $1.00 consensus (86.38 +0.76) -Update-

17:26 JEC Jacobs will replace Avaya in the S&P 500 (81.69 +2.141) -Update-

S&P MidCap 400 constituent Jacobs Engineering (JEC) will replace Avaya (AV) in the S&P 500, and CF Industries Holdings (CF) will replace Jacobs Engineering in the S&P MidCap 400, after close of trading on Thursday, October 25. AV is being acquired by Silver Lake Partners and TPG Capital in a deal expected to close on or about that date, pending final approvals. Standard
17:25 NVLS Novellus Conf Call Summary (27.63 ) -Update-

Bought back ~6.2 mln shares (5% of the co. outstanding shares) at an average price of $27.60 and note that the the cost of that was roughly equivalent to their cash flow from operations. Have $350 mln left on the buyback and say that they will continue to be active but won’t say anything about future authorizations.. Noting they had great expense control. Noting that demand continued to weaken throughout the qtr in both memory and Foundry. They also note, basically in the next sentence, that demand continues to be strong but that macro-economic factors are making their customers cautious. Noting that the memory industry in general looks good, saying that with the increased use of flash memory in different applications, short of a collapse in the financial markets things look to be pretty solid. Saying that they would expect if bookings come in as guided, then they should see revs pick up in Q1. Noting that they see foundries as nothing but a good story… though would note he also said he can see nothing negative about semiconductors. Saying they see their Q4 guidance as representing capacity expansion amongst their customers. Noting that they expect the move to copper in memory to accelerate in 2H08. Noting that OpEx should be down 2-4 mln in Q4. Commenting that they are still committed to CMT business. Saying that guidance assumes share count is unchanged from the beginning of the qtr. Note: Obviously this implies that they are expecting to outperform given that they are planning to buy back a decent number of shares during the qtr.
17:25 BOFI BOFI Holding names Gregory Garrabrants CEO (7.069 +0.039)

Co announces that its board of directors has unanimously appointed Gregory Garrabrants to serve as the co’s CEO. Gary Evans has relinquished the CEO role, but remains as President and COO of the Bank.
17:24 JNPR Juniper Networks on call sees Q4 EPS $0.24 vs $0.23 consensus; sees revs $770-790 mln vs $751.3 mln consensus -Update-

17:24 STM sees Q4 revs growth of 4-9%, which equates to ~2.67-2.80 bln vs $2.65 bln Reuters consensus

17:23 STM sees Q4 revs growth of 4-9% from Q3

17:22 INFN Infinera on conf call: co guides Q4 EPS above consensus (26.66 +1.04) -Update-

Co guides to Q4 EPS of $0.02-0.04 vs consensus of $(0.01)…stock at 24.26.
17:21 STM prelim $0.20, ex-items, vs $0.18 Reuters consensus; revs $2.57 bln vs $2.54 bln Reuters consensus

17:21 CF CF Industries to replace Jacobs Engineering in MidCap 400 - DJ (81.50 +4.90) -Update-

17:21 RPT Ramco-Gershenson reports in-line; guides FY07 FFO’s in-line (30.75 +0.36)

Reports Q3 (Sept) earnings of $0.66 per share, in-line with the Reuters Estimates consensus of $0.66; revenues fell 2.6% year/year to $37.8 mln vs the $38.3 mln consensus. Co sees FY07 FFO’s of $2.61-2.69 vs $2.64 Reuters consensus.
17:20 JEC Jacobs to replace Avaya in S&P 500 - DJ (81.69 +2.14)

17:20 CYMI Cymer: On Q3 call, co sees Q4 gross margins of 50% (42.23 +0.9 -Update-

Call ongoing.
17:15 AJG Arthur J. Gallagher misses by $0.07, misses on revs (27.03 -0.57)

Reports Q3 (Sep) earnings of $0.54 per share, $0.07 worse than the Reuters Estimates consensus of $0.61; revenues rose 0.7% year/year to $424.1 mln vs the $451.6 mln consensus.
17:14 CAKE Cheesecake Factory Conference Call Update II (23.30 -0.44) -Update-

Based on co’s current outlook for warehouse club sales they expect bakery sales to be approximately flat to down 1% in fiscal 2007 compared to the prior year.
17:14 DEO Diageo plc announces 2 bond issues; $500 mln and $1 bln (90.66 +0.92)

Co launched and priced $500 mln of long 5-year and $1 bln of 10-year SEC registered securities. The bonds were issued by Diageo Capital plc, with payment of principal and interest fully guaranteed by Diageo plc. Due on 30 January 2013, the long 5-year issue pays a coupon of 5.20%. Due on 23 October 2017, the 10-year issue pays a coupon of 5.75%. Citi, Banc of America Securities LLC and Morgan Stanley were joint book-running managers. RBS Greenwich Capital and HSBC were co-managers. Proceeds from this issuance will be used for general corporate purposes.
17:12 CAKE Cheesecake Factory Conference Call Update (23.30 -0.44) -Update-

On their conference call co notes their longer term expectations remains in the range of menu price increases or 1-2%. For 2007, co’s overall revenue growth target is 15-16%. Which translates into 15% growth in the 4th quarter. This is a little bit lower than our previous guidance and reflects the softer sales they experienced in the second half of September and the first couple weeks of October. Overall comparable calls are tracking between flat and a positive 1%. Co is on target to achieve our goal of opening as many as 21 new restaurants including five Grand Lux Cafe.
17:12 AJG prelim $0.54 vs $0.61 Reuters consensus, $0.63 First Call

17:10 CNP CenterPoint subsidiary closes on $500 mln of senior notes (16.05 -0.11)

Co announces that CenterPoint Energy Resources closed on $250 mln of 6.125 percent senior unsecured notes due Nov. 1, 2017, and $250 mln of 6.625 percent senior unsecured notes due Nov. 1, 2037. CERC is CenterPoint Energy’s natural gas distribution, competitive natural gas sales and services, and natural gas pipeline and gas gathering subsidiary. Net proceeds will be used for general corporate purposes, including the repayment or refinancing of $300 mln of 6.50 percent debentures due Feb. 1, 2008.
17:08 RFMD RF Micro Device earnings color (7.22 +0.09) -Update-

Reuters Estimates is telling us that excluding non-recurring items, an actual of $0.11 is comparable to their consensus of $0.07. See 16:13 comment for full report.
17:07 BRCM Broadcom: On call, co guides Q4 product revs to $960-990 mln (consensus $986.56); however, , this does not include any revs associated with patent license signed with VZ in July (42.06 +0.36) -Update-

The reason for exclusion of Verizon revs is that co has not received count of phones from Verizon… BRCM notes that, excluding the margin impact from the rise in license in Q4, co expects to see an additional decline in gross margin, slightly greater than experienced in Q3… stock trading at $36.75 in after hours
17:05 XFN Xfone discloses agreement for investors to purchase 1 mln shares at $3.00 under existing registration statement (3.00 +0.09)

From 8-K: “On October 23, 2007, Xfone entered into Subscription Agreements with 15 investors affiliated with Gagnon Securities who agreed to purchase an aggregate of 1,000,000 shares of the Registrant’s common stock, par value $0.001 per share at a price of $3.00 per share, for a total subscription amount of $3,000,000. The Offering was made by the Registrant, acting without a placement agent, pursuant to the Registrant’s Registration Statement on Form SB-2 which was declared effective by the U.S. Securities and Exchange Commission on August 6, 2007.”
17:04 CAV Cavalier Homes misses by $0.04; misses on revs (2.73 +0.03)

Reports Q3 (Sep) loss of ($0.15) per share, $0.04 worse than the Reuters Estimates consensus of ($0.11); revenues rose 2.0% year/year to $51.7 mln vs the $52.27 mln consensus.
17:03 TUP Tupperware beats by $0.16, beats on revs; guides Q4 EPS below consensus, revs below consensus (35.51 -0.03)

Reports Q3 (Sep) earnings of $0.37 per share, excluding non-recurring items, $0.16 better than the Reuters Estimates consensus of $0.21; revenues rose 15.1% year/year to $454.7 mln vs the $433.6 mln consensus. Co issues downside guidance for Q4, sees EPS of $0.78-0.83, excluding non-recurring items, vs. $0.88 consensus; sees Q4 revs of $530-540 mln vs. $541.57 mln consensus.
17:02 IPCR IPC Holdings reports Q3 net operating income of $1.19 vs $1.47 in yr ago period; reports revs up 12% yr/yr to $160.7 mln (28.40 +0.73)

17:02 ISNS Image Sensing Systems reports Q3 EPS of $0.34 vs $0.19 yr ago; revs rise 40% to $4.2 mln (12.88 +0.19)

17:02 XL XL Capital announces ‘08 planned retirement of Brian O’Hara, President and CEO, and Michael Esposito Jr., Chairman (74.53 -0.36)

Co announces that Brian O’Hara, President and CEO of XL, has informed the XL Board of Directors of his decision to retire as President and CEO in mid-2008. Accordingly, the Board of Directors has implemented its CEO succession plan including the authorization of a Succession Committee to lead the new CEO selection process. In addition, Michael Esposito Jr., Chairman, has advised the Board of Directors that he will retire from the Board upon the appointment of Brian O’Hara’s successor.
17:02 TUP sees Q4 $0.78-0.83 vs $0.88 Reuters consensus; sees revs $530-540 mln vs $541.57 mln Reuters consensus

17:01 TUP sees FY07 $2.10-2.15 vs $2.10 Reuters consensus; sees revs $1.93-1.94 bln vs $1.91 bln Reuters consensus

17:01 TUP prelim $0.37, ex items vs $0.21 Reuters consensus; revs $454.7 mln vs $433.57 mln Reuters consensus

17:00 QLGC QLogic earnings color (13.48 +0.33) -Update-

Reuters Estimates is telling us that excluding amortization of purchased intangible assets, acquisition-related stock-based compensation and special charges but including stock option expenses, an actual of $0.19 is comparable to their consensus of $0.15. See 16:33 comment for full report.
17:00 ISSI Integrated Silicon board authorizes $30 mln share repurchase program (6.24 +0.09)

16:59 NARA Nara Bancorp beats by $0.02; guides FY07 EPS below consensus (15.65 +0.29)

Reports Q3 (Sep) earnings of $0.35 per share, excluding non-recurring items, $0.02 better than the Reuters Estimates consensus of $0.33. Co issues downside guidance for FY07, sees EPS of $1.25-1.27 vs. $1.29 consensus. Co says, “We expect that our Q4 results will be negatively impacted by three trends: 1) we expect to see further compression in our net interest margin as a result of the Fed rate cut; 2) the premiums received on SBA loan sales are declining due to investor expectation of faster prepayment speeds; and 3) deposit growth will continue to be challenging. On the positive side, we expect that these trends will be offset by continued strong loan production and solid asset quality.”
16:57 MTCT MTC Tech wins $6.7 mln in Air Force awards for education and training (18.98 -0.29)

The co announces “that the co has won a $2.1 mln award to support Headquarters Air Education and Training Command, and a $4.6 mln award to provide courseware for Joint Imagery Analysis Courses.”
16:57 NARA sees FY07 $1.25-1.27 vs $1.29 Reuters consensus

16:56 NARA prelim $0.35 vs $0.33 Reuters consensus

16:56 SUPX Supertex (42.80 +0.27) -Update-

Reuters Estimates is telling us that an actual of $0.35, ex items is comparable to their consensus of $0.35. See 16:41 comment for the full earnings report.
16:53 PTP Platinum Underwriters beats by $0.25, beats on revs (35.68 +0.35)

Reports Q3 (Sep) earnings of $1.37 per share, $0.25 better than the Reuters Estimates consensus of $1.12; revenues fell 14.5% year/year to $290.3 mln vs the $281.4 mln consensus. Co says, “Plentiful reinsurance capacity resulting from historically good market conditions and light catastrophe losses in combination with some companies’ drive for growth and diversification will likely put downward pressure on reinsurance rates across nearly all lines and geographies. However, given the significant asset base we have developed over the past five years and with our focus on underwriting for profitability, we believe that our prospects for continuing to build book value per share are strong in 2008 and beyond.”
16:51 CAR Avis Budget acquires interest in Carey International for ~$60 mln (21.62 +0.36)

Co announces that it has acquired a significant interest in Carey International. In connection with this transaction, Avis Budget Group invested approximately $60 mln in cash and now owns approximately 45 percent of Carey’s common stock. In addition, Avis Budget also obtained a one-year option to increase its ownership stake in Carey to approximately 80 percent, subject to certain conditions, which would likely include the assumption or repayment of Carey’s existing indebtedness.
16:51 SEIC SEI Investments announces increase in stock repurchase program (28.09 +0.1

The co announces that “its Board of Directors has approved an increase in its stock repurchase program by an additional $100 million.”
16:50 TRMK Trustmark misses by $0.01 (25.86 -0.16)

Reports Q3 (Sep) earnings of $0.51 per share, $0.01 worse than the Reuters Estimates consensus of $0.52. “We believe Trustmark’s credit culture and underwriting processes have well-positioned the organization to face the challenges presented by the current economic environment. While Trustmark has no sub-prime mortgage loans, we are not immune to the credit challenges and current market conditions facing the financial services industry. During the third quarter of 2007, nonperforming loans increased $17.7 mln due principally to two relationships with residential real estate developers originated in our Florida and Tennessee markets that were impacted by the residential real estate slowdown. Based upon current economic conditions, we believe Trustmark is adequately reserved.”
16:50 CEO CNOOC CFO: Not interested in US Gulf Energy assets - DJ (190.21 +9.37)

Cnooc CFO: Focusing on growth in Asia, Africa, not Mideast
16:49 ANAD Anadigics beats by $0.05, reports revs in-line; guides Q4 EPS above consensus (19.34 +0.31)

Reports Q3 (Sep) earnings of $0.11 per share, $0.05 better than the Reuters Estimates consensus of $0.06; revenues rose 10.4% year/year to $59.5 mln vs the $59.3 mln consensus. Co issues upside guidance for Q4, sees EPS of $0.11 - $0.13 vs. $0.08 consensus.
16:48 SRI Stoneridge announces Brazilian joint venture IPO filing (9.36 -0.41)

The co announces “that its PST Industria Eletronica da Amazonia joint venture has filed for an initial public offering with the Brazilian Securities Commission (Comissao de Valores Mobiliarios). Stoneridge currently holds a 50% equity interest in PST.”
16:47 BRCM Broadcom Earnings Color (42.06 +0.36) -Update-

Reuters Estimates is telling us that, excluding loss on strategic investments and non-operating gains, an actual of $0.05 per share is comparable to Reuters estimates of $0.07. See earlier comment at 16:16.
16:47 GSIG GSI Group earnings color (10.80 +0.14) -Update-

Reuters Estimates is telling us that the reported actual of $0.18 is comparable to their consensus of $0.15. See 16:32 comment for the full earnings report.
16:46 TRMK prelim $0.51 vs $0.52 Reuters consensus

16:46 IPAR Inter Parfums reports Q3 revs slightly below consensus; issues FY07 guidance slightly below consensus (25.69 +0.90)

Co reports Q3 revs of $102.3 mln vs $104.97 mln Reuters consensus. IPAR sees FY07 EPS of $1.04 vs $1.06 Reuters consensus; sees revs $378.00 mln vs $379.05 mln Reuters consensus. “The 4% increase in U.S. sales to $14.2 mln was achieved despite the high threshold set in the same period of 2006. In last year’s third quarter, U.S. sales were $13.6 mln, or 64% ahead of the third quarter of 2005, primarily due to first time shipments of the Discover Collection of five fragrances and a full line of bath and body to all Banana Republic’s North American stores. The current third quarter sales increase reflects the staged rollout of new products to additional Gap stores which is still underway, as well as new product launches for both Banana Republic and Gap stores.” Separately, the co reported that the license agreement concluded in March 2006 between Inter Parfums and Quiksilver has been extended to men’s fragrances under the Quiksilver brand. The launch of the first Quiksilver men’s fragrance is scheduled for fall 2008.
16:46 BTUI BTU Int’l misses by $0.01, beats on revs; guides Q4 revs above consensus (12.83 +0.44)

Reports Q3 (Sep) earnings of $0.06 per share, $0.01 worse than the Reuters Estimates consensus of $0.07; revenues fell 9.8% year/year to $16.5 mln vs the $14.3 mln consensus. Co issues upside guidance for Q4, sees Q4 revs growth of 10%, which equates to ~ $18.2 mln vs. $14.80 mln consensus; co sees
16:45 ANAD sees Q4 sales increasing sequentially by approx 10-14%

16:45 AXS AXIS Capital announces extension of CEO employment agreement extended until Dec 31, 2009 (38.44 -0.17)

16:45 IIG Imergent: Steven Mihaylo discloses 17.8% stake in SC 13G/A, up from 10% previously (22.14 -0.04)

16:45 TNRO Terra Nostra: Ospraie Mgmt discloses 8.3% stake in SC 13G filing (5.13 -0.35)

16:44 GSS Golden Star Resources halted - see info out at 16:35 (3.82 +0.04) -Update-

16:44 NVLS Novellus guiding Q4 bookings up 5-15%, shipments at $365-390 mln -Update-

16:43 ANAD sees Q4 $0.11-0.13 vs $0.08 Reuters consensus

16:43 ANAD prelim $0.11, excluding and certain costs associated with the RF Group purchase $0.06 Reuters consensus; revs $59.5 mln vs $59.32 mln Reuters consensus

16:42 NVLS Novellus Guiding Q4 EPS $0.34-0.37 vs $0.33 consensus -Update-

16:42 NVLS Novellus Guiding Q4 revs at $355-365 mln vs $370.4 mln consensus. -Update-

gross margin at 49%
16:42 BTUI sees Q4 revs growth of 10%, which equates to ~$18.2 mln vs $14.80 mln Reuters consensus; co sees earnings up by ~60% sequentially

16:42 EFII Elec For Imaging misses by $0.02, reports revs in-line; guides Q4 EPS below consensus, revs below consensus (27.85 +1.11)

Reports Q3 (Sep) earnings of $0.34 per share, $0.02 worse than the Reuters Estimates consensus of $0.36; revenues rose 14.5% year/year to $158.3 mln vs the $158.9 mln consensus. Co issues downside guidance for Q4, sees EPS of $0.35 - $0.38 vs. $0.45 consensus; sees Q4 revs of $160 - $165 vs. $169.52 mln consensus.
16:41 DDUP Data Domain beats by $0.02, beats on revs (40.39 +1.44)

Reports Q3 (Sep) earnings of $0.04 per share, excluding non-recurring items, $0.02 better than the Reuters Estimates consensus of $0.02; revenues rose 189.3% year/year to $32 mln vs the $30 mln consensus.
16:41 SUPX Supertex reports Q2 (Sep) results, beats on revs (42.80 +0.27)

Reports Q2 (Sep) earnings of $0.32 per share, includes stock options expense, not comparable to the Reuters Estimates consensus of $0.35; revenues fell 16.9% year/year to $22 mln vs the $21.7 mln consensus. Co also says “We are projecting our third fiscal quarter to be flat sequentially (Consensus for Q4 is EPS of $0.38 on revs of $22.54 mln) due to uncertainty in near-term E.L driver sales and potential seasonality dip in medical ultrasound products, although orders appear to be robust at this time. In addition, there could be a short-term pause in the ramp-up of our L.E.D backlight drivers sales as inventory of existing C.C.F.L products sE.Lls through the HDTV retail channE.L over the coming holidays. We expect our L.E.D driver shipments to resume growth in our fourth fiscal quarter and beyond, as the transition from C.C.F.L to L.E.D backlights becomes more compE.Lling due to its superior performance in contrast ratio, color gamut, localized dimming and low power consumption. For the second fiscal half, we are projecting our overall sales to be modestly up sequentially.”
16:41 BTUI prelim $0.06 vs single analyst estimate of $0.07; revs $16.5 mln vs single estimate of $14.3 mln

16:41 FBN Furniture Brands unveils strategic plan to investment community (12.75 +0.1

Co hosted a meeting with the investment community to unveil the co’s strategic plan. Co said “Our strategic plan is to move to a more focused organization that is integrated and serves the mid-and high-end markets for residential furnishings. As part of this plan, we have a set of shorter- and longer-term business interventions that we are implementing now.” The strategic plan is composed of four key elements that will touch every part of Furniture Brands. The four key elements of the strategy are: Build Our Brand Power; Win in The Store; Deliver Operational Excellence; Grow and Develop Our People.
16:40 RJF Raymond James beats by $0.02, beats on revs (32.79 +0.12)

Reports Q4 (Sep) earnings of $0.53 per share, $0.02 better than the Reuters Estimates consensus of $0.51; revenues rose 17.2% year/year to $691.6 mln vs the $656.6 mln consensus.
16:39 PPDI PPD Inc. reports EPS in-line, beats on revs; increase in annual cash dividend to $0.40 from $0.12 (38.82 )

Reports Q3 (Sep) earnings of $0.32 per share, in-line with the Reuters Estimates consensus of $0.32; revenues rose 14.1% year/year to $357.2 mln vs the $332.2 mln consensus. Co that PPD also announced its board of directors has amended the annual cash dividend policy to increase the annual dividend rate from $0.12 to $0.40 per year, payable quarterly at a rate of $0.10 per share. PPD expects the new dividend rate will be effective beginning in the fourth quarter 2007.
16:38 MCHP Microchip misses by $0.01, reports revs in-line; guides for Q3 (30.68 +0.03)

Reports Q2 (Sep) earnings of $0.34 per share, excluding non-recurring items but including stock based compensation expense, $0.01 worse than the Reuters Estimates consensus of $0.35; revenues rose 59.7% year/year to $258.6 mln vs the $259 mln consensus. Co issues guidance for Q3, sees EPS of $0.34-0.37, ex items does not compare to the $0.34 consensus. (Consensus estimates include stock based compensation.)
16:38 ALTR Altera reports EPS in-line, misses on revs; guides Q4 revs below consensus (23.32 +0.01)

Reports Q3 (Sep) earnings of $0.20 per share, in-line with the Reuters Estimates consensus of $0.20; revenues fell 1.2% year/year to $315.8 mln vs the $324.9 mln consensus. Co issues downside guidance for Q4, sees Q4 revs flat to -4% sequentially, or roughly $303.2-315.8 mln vs. $335.54 mln consensus. Sees Q4 gross margins of 63-64%. “The September quarter proved more challenging than anticipated. Sales to the communications and industrial markets were below expectations, although consumer market segment sales were up strongly. The resulting end market mix reduced gross margin this quarter. Reflecting continued cost control efforts across the company, operating expenses came in lower than forecast, more than offsetting the lower than planned gross margin… New product sales once again generated good double digit sequential growth and are now 35 percent of sales. With the Stratix III FPGA family now shipping, we are the only programmable logic company with 65-nm devices optimized for low power, which gives us a unique competitive position at the leading edge of FPGA deployment. The Stratix III introduction is going smoothly, and we anticipate rapid customer adoption.”
16:38 HSTM Healthstream reports in-line EPS; beats on revs (3.72 +0.15)

Reports Q3 (Sep) earnings of $0.03 per share, in-line with Reuters Estimates consensus; revenues rose 58% year/year to $11.8 mln vs the $10.24 mln consensus.
16:36 CLZR Candela reports Q1 (Sep) results, misses on revs (7.28 -0.11)

Reports Q1 (Sep) earnings of $0.01 per share, includes after-tax proceeds from remaining payments associated with the sale of SOLX, may not be comparable to the Reuters Estimates consensus of $0.01; revenues rose 6.0% year/year to $35.5 mln vs the $38.9 mln consensus.
16:36 ACTL Actel reports Q3 revenues fell 4% year/year to $47.9 mln vs the $48.2 mln consensus, does not report EPS due to ongoing options review

16:36 CEC CEC Entertainment beats by $0.02, reports revs in-line; guides FY07 EPS in-line; guides FY08 EPS below consensus (25.55 +0.03)

Reports Q3 (Sep) earnings of $0.50 per share, $0.02 better than the Reuters Estimates consensus of $0.48; revenues rose 1.4% year/year to $197.5 mln vs the $196.3 mln consensus. CEC announces a $200 mln increase in share repurchase authorization. Co issues in-line guidance for FY07, sees EPS of $1.98-2.02 vs. $2.00 consensus. Co issues downside guidance for FY08, sees EPS of $2.10-2.20 vs. $2.29 consensus.
16:35 GSS Golden Star Resources proposed offering of convertible senior unsecured debentures and preannounces Q3 results (3.82 +0.04)

The co announces “its intent to offer and sell an aggregate principal amount of up to $125 mln of Convertible Senior Unsecured Debentures.” Note co also pre-announced earnings in Canadian dollars net loss for Q3 2007 of $0.06 compared to a $0.01 loss in Q3 of 2006.
16:34 PFWD Phase Forward beats by $0.02, beats on revs; guides Q4 EPS in-line, revs above consensus (19.60 -0.59)

Reports Q3 (Sep) earnings of $0.16 per share, $0.02 better than the Reuters Estimates consensus of $0.14; revenues rose 24.4% year/year to $34.9 mln vs the $33.7 mln consensus. Co issues mixed guidance for Q4, sees EPS of $0.15-0.16 vs. $0.15 consensus; sees Q4 revs of $36.0-36.8 mln vs. $35.34 mln consensus.
16:34 EPIQ EPIQ Systems reports EPS in-line, beats on revs (19.51 +0.15)

Reports Q3 (Sep) earnings of $0.13 per share, in-line with the Reuters Estimates consensus of $0.13; revenues rose 14.9% year/year to $44.8 mln vs the $41.4 mln consensus.
16:33 ECOL sees FY07 $1.02-1.05 vs $1.06 Reuters consensus

16:33 QLGC QLogic reports Q2 (Sep) results, revs in-line (13.48 +0.33)

Reports Q2 (Sep) non-GAAP earnings of $0.22 per share, excluding non-recurring items, but excludes stock based compensation that analysts are including, may not be comparable to the Reuters Estimates consensus of $0.15; revenues fell 3.4% year/year to $140.3 mln vs the $139.4 mln consensus.
16:33 ATB prelim $0.32 vs $0.29 Reuters consensus; revs $17.5 mln vs $17.65 mln Reuters consensus

16:32 ECOL prelim $0.25 vs $0.26 Reuters consensus; revs $39.4 mln vs $39.99 mln Reuters consensus

16:32 GSIG GSI Group reports Q3 (Sep) results, beats on revs; guides Q4 revs in-line (10.80 +0.14)

Reports Q3 (Sep) GAAP earnings of $0.18 per share, incl charges, may not be comparable to the Reuters Estimates consensus of $0.15; revenues rose 2.9% year/year to $84 mln vs the $82.2 mln consensus. Co issues EPS guidance for Q4, sees EPS of $0.13-0.17, includes charges, may not be comparable to $0.15 consensus; sees Q4 revs of $80.0-84.0mln vs. $81.50 mln consensus.
16:32 WSCI WSI Industries reports AugQ revs up 21%, no estimates (7.08 +0.23)

Co reports Q4 (Aug) EPS of $0.08. Revenue rose 21% yr/yr to $5.0 mln. There are no analyst estimates.
16:31 EFII sees Q4 $0.35-0.38 vs $0.45 Reuters consensus; sees revs $160-165 mln vs $169.52 mln Reuters consensus

16:31 MCHP sees Q3 $0.34-0.37 vs $0.34 Reuters consensus

16:31 EFII prelim $0.34 vs $0.36 Reuters consensus, $0.37 First Call; revs $158.3 mln vs $158.87 mln Reuters consensus

16:30 MCHP prelim $0.38, ex items vs $0.35 Reuters consensus; revs $258.6 mln vs $258.98 mln Reuters consensus

16:30 ENTU Entrust reports EPS in-line, misses on revs; guides FY07 EPS in-line (2.05 +0.01)

Reports Q3 (Sep) net of breakeven, in-line with the Reuters Estimates consensus of ($0.00); revenues fell 0.4% year/year to $23.9 mln vs the $25.6 mln consensus. Co issues in-line guidance for FY07, sees EPS of $0.00 vs. $0.00 consensus. Co also announces they continue to target a second half 2007 net loss in accordance with GAAP of $0.02 per share. On a non-GAAP basis, the co continues to target a profit of $0.04 per share for the second half of 2007.
16:30 QLGC prelim $0.22 may not be comparable to $0.15 Reuters consensus; revs $140.3 mln vs $139.44 mln Reuters consensus

16:30 CEPH Cephalon announces positive results from its pivotal study of TREANDA in patients with non-hodgkin’s Lymphoma (71.08 +0.07)

Co announces positive results from a Phase 3 clinical trial of TREANDA in patients with indolent non-Hodgkin’s lymphoma whose cancer is no longer responsive to treatment with rituximab. The study met its primary endpoints of overall response rate and median duration of response, while demonstrating a manageable tolerability profile. According to the National Cancer Institute, an estimated 30,000 people in the United States will be diagnosed in 2007 with indolent NHL, a serious and slow growing cancer of the lymphatic system that is difficult to treat because patients are prone to relapse after treatment.
16:30 RJF prelim $0.53 vs $0.51 Reuters consensus; revs $691.6 mln vs $656.61 mln Reuters consensus

16:30 CAKE Cheesecake Factory misses by $0.01, misses on revs (23.30 -0.44)

Reports Q3 (Sep) earnings of $0.26 per share, $0.01 worse than the Reuters Estimates consensus of $0.27; revenues rose 15.4% year/year to $375.5 mln vs the $382.8 mln consensus. The co also announced its preliminary growth plan for fiscal 2008, which is aimed at continued expansion of its concepts in high-quality locations, returning cash to stockholders through share repurchases and managing its business to drive improvement in the co’s operating income margin. The co plans to open as many as 17 new restaurants in fiscal 2008 consisting of as many as 12 to 13 Cheesecake Factory restaurants, three to four Grand Lux Cafes and one Rock Sugar Pan Asian Kitchen.
16:29 XL XL Capital reports Q3 (Sep) results (74.53 -0.36)

Reports Q3 (Sep) earnings of $3.13 per share, may not be comparable to the Reuters Estimates consensus of $2.38.
16:29 CRI Carter Holdings beats by $0.02, reports revs in-line; guides Q4 EPS below consensus, revs below consensus (18.53 -0.45)

Reports Q3 (Sep) earnings of $0.58 per share, $0.02 better than the Reuters Estimates consensus of $0.56; revenues rose 4.8% year/year to $410.9 mln vs the $412.8 mln consensus. Co issues downside guidance for Q4, sees EPS of $0.50 vs. $0.54 consensus; sees Q4 revs of $388 mln vs. $401.44 mln consensus.
16:29 EPIC Epicor Software misses by $0.01, misses on revs; guides Q4 EPS in-line, revs in-line; guides FY08 EPS below consensus, revs below consensus (12.94 -0.12)

Reports Q3 (Sep) earnings of $0.22 per share, $0.01 worse than the Reuters Estimates consensus of $0.23; revenues rose 7.7% year/year to $103.1 mln vs the $107.5 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.26-0.27 vs. $0.29 consensus; sees Q4 revs of $110-112 mln vs. $119.43 mln consensus. Co issues downside guidance for FY08, sees EPS of $0.96-0.99 vs. $1.02 consensus; sees FY08 revs of $458-468 mln vs. $473.64 mln consensus.
16:29 BOW Bowater and Abitibi-Consolidated and Bowater confirm combination approved by DOJ (17.55 +1.2 -Update-

16:28 CLMS Calamos Asset misses by $0.02, misses on revs (31.92 +0.79)

Reports Q3 (Sep) earnings of $0.32 per share, $0.02 worse than the Reuters Estimates consensus of $0.34; revenues fell 0.1% year/year to $118.5 mln vs the $120.2 mln consensus. Co says that in Aug 2007 it repurchased 1.2 mln shares, representing 5.4% of shares outstanding, which completed the share repurchase program approved in Oct 2006. In Oct 2007, the co authorized the repurchase of up to 2 mln additional shares.
16:28 ACE ACE Limited beats by $0.25

Reports Q3 (Sep) earnings of $2.06 per share, excluding non-recurring items, $0.25 better than the Reuters Estimates consensus of $1.81.
16:28 AFL AFLAC beats by $0.03, reports revs in-line; guides Q4 EPS below consensus (59.10 +0.89)

Reports Q3 (Sep) earnings of $0.85 per share, $0.03 better than the Reuters Estimates consensus of $0.82; revenues rose 5.1% year/year to $3.86 bln vs the $3.83 bln consensus. Co issues downside guidance for Q4, sees EPS of $0.75-0.79 vs. $0.82 consensus. Co says, ‘As we look to 2008, I believe we are also well-positioned to achieve our objective of increasing operating earnings per diluted share by 13% to 15%, before the impact of the yen.”
16:27 SVVS SAVVIS Comm beats by $0.10, misses on revs; guides Q4 revs below consensus; guides FY08 revs below consensus (41.29 +0.05)

Reports Q3 (Sep) earnings of $0.10 per share, $0.10 better than the Reuters Estimates consensus of ($0.00); revenues fell 1.8% year/year to $190.3 mln vs the $196.3 mln consensus. Co issues downside guidance for Q4, sees Q4 revs of $197 - $200 mln vs. $207.06 mln consensus. Co issues downside guidance for FY08, sees FY08 revs of $910 - $925 vs. $931.28 mln consensus.
16:27 LDIS Leadis Tech misses by $0.11, misses on revs; guides Q4 revs below consensus (3.03 +0.01)

Reports Q3 (Sep) loss of $0.29 per share, $0.11 worse than the Reuters Estimates consensus of ($0.18); revenues rose 2.1% year/year to $9.9 mln vs the $10.2 mln consensus. Co issues downside guidance for Q4, sees Q4 revs of 6-7 vs. $11.62 mln consensus. “Our primary goals entering 2007 were to create greater value in our display driver business through product innovation and to diversify our business beyond display driver ICs… We believe we have built a foundation for future success on these two goals. Our challenge is now to turn the innovation into profitable revenue.”
16:27 SEAB Seabright Insurance Holdings misses by $0.01, reports revs in-line (17.93 +0.52)

Reports Q3 (Sep) earnings of $0.46 per share, $0.01 worse than the Reuters Estimates consensus of $0.47; revenues rose 26.4% year/year to $66.7 mln vs the $66.7 mln consensus.
16:26 CSCD Cascade Microtech beats by $0.02, reports revs in-line; guides Q4 EPS below consensus, revs below consensus (8.55 +0.10)

Reports Q3 (Sep) loss of $0.02 per share, $0.02 better than the Reuters Estimates consensus of ($0.04); revenues fell 7.2% year/year to $21.3 mln vs the $21.5 mln consensus. Co issues downside guidance for Q4, sees EPS of (0.02)-0.02 vs. $0.05 consensus; sees Q4 revs of 20-22 vs. $23.68 mln consensus.
16:26 MANH Manhattan Assoc beats by $0.02, beats on revs; guides Q4 EPS in-line; guides FY07 EPS in-line (29.74 +0.73)

Reports Q3 (Sep) earnings of $0.34 per share, excluding non-recurring items, $0.02 better than the Reuters Estimates consensus of $0.32; revenues rose 17.0% year/year to $84.6 mln vs the $82.3 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.35-0.40, excluding non-recurring items, vs. $0.38 consensus. Co issues in-line guidance for FY07, sees EPS of $1.29-1.34, excluding non-recurring items, compared to previous guidance of $1.27-1.31, vs. $1.30 consensus.
16:26 SIAL Sigma-Aldrich misses by $0.01, beats on revs; guides FY07 EPS in-line (50.11 +0.49)

Reports Q3 (Sep) earnings of $0.54 per share, $0.01 worse than the Reuters Estimates consensus of $0.55; revenues rose 14.0% year/year to $503.2 mln vs the $493.5 mln consensus. Co raises guidance for FY07, to EPS of $2.25-2.35 from $2.20-2.30 vs. $2.28 consensus.
16:25 CSGS CSG Systems reports EPS in-line, revs in-line; guides Q4 revs in-line (20.63 +0.24)

Reports Q3 (Sep) earnings of $0.37 per share, excluding the impact of the acquired Prairie Interactive Messaging business, in-line with the Reuters Estimates consensus of $0.37. Co issues guidance for Q4, sees EPS of $0.40-0.42, includes impact of the acquired ComTec and Prairie businesses, may not be comparable to $0.39 consensus; sees Q4 revs of $111-113 vs. $110.17 mln consensus.
16:25 SVVS sees Q4 revs $197-200 mln vs $207.06 mln Reuters consensus

16:24 CTX Centex beats by $0.26, beats on revs (24.65 -0.92)

Reports Q2 (Sep) loss of $5.26 per share, $0.26 better than the Reuters Estimates consensus of ($5.52); revenues fell 21.1% year/year to $2.22 bln vs the $2.2 bln consensus. Co says, “Market conditions were extremely challenging during the quarter, reflecting the serious disruptions in the credit and mortgage markets that occurred during that period. In response, we meaningfully reduced prices in order to improve affordability for our home buyers. These actions were consistent with our continued focus on selling homes and generating cash as we structure for profitability.”
16:24 SVVS sees FY08 revs $910-925 mln vs $931.28 mln Reuters consensus

16:24 VOCS Vocus beats by $0.03, beats on revs; guides Q4 EPS in-line, revs in-line (30.99 +1.03)

Reports Q3 (Sep) earnings of $0.14 per share, $0.03 better than the Reuters Estimates consensus of $0.11; revenues rose 40.2% year/year to $15.1 mln vs the $14.5 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.12-0.13 vs. $0.13 consensus; sees Q4 revs of $15.6-15.8 mln vs. $15.59 mln consensus.
16:24 SVVS prelim $0.10 vs $0.00 Reuters consensus; revs $190.3 mln vs $196.25 mln Reuters consensus

16:23 HLIT Harmonic announces offering of 12.9 mln shares of common stock (11.57 -0.05)

16:23 CHRW C.H. Robinson reports EPS in-line, misses on revs (51.84 -1.24)

Reports Q3 (Sep) earnings of $0.48 per share, in-line with the Reuters Estimates consensus of $0.48; revenues rose 8.9% year/year to $1.87 bln vs the $1.91 bln consensus.
16:23 AMSG AmSurg reports EPS in-line, beats on revs; guides Q4 EPS in-line; guides FY07 EPS above consensus, revs in-line (26.08 +2.57)

Reports Q3 (Sep) earnings of $0.35 per share, in-line with the Reuters Estimates consensus of $0.35; revenues rose 16.3% year/year to $132.1 mln vs the $129.9 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.36 - $0.38 vs. $0.37 consensus. Co issues mixed guidance for FY07, sees EPS of $1.43 - $1.45 vs. $1.41 consensus; sees FY07 revs of $520 - $530 mln vs. $524.69 mln consensus.
16:23 PTP prelim $1.37 vs $1.12 Reuters consensus; revs $343.07 mln vs $281.43 mln Reuters consensus

16:22 CNW Con-way misses by $0.10, reports revs in-line; guides FY07 EPS below consensus (43.87 +0.13)

Reports Q3 (Sep) earnings of $0.87 per share, excluding non-recurring items, $0.10 worse than the Reuters Estimates consensus of $0.97; revenues rose 3.2% year/year to $1.11 bln vs the $1.11 bln consensus. Co issues downside guidance for FY07, sees EPS of $3.34-3.44, excluding non-recurring items, vs. $3.47 consensus. Co says, “While we are encouraged with customer response to Con-way Freight’s growth initiatives, the market continues to be very price sensitive. Tonnage per day had a respectable gain over last year’s third quarter; however, yields remain under pressure, a market dynamic that we expect will continue to dampen profit growth in LTL freight through the remainder of the year.”
16:22 ACE prelim $2.06 ex items vs $1.81 Reuters consensus

16:21 CB Chubb beats by $0.23; guides FY07 EPS in-line (53.55 -0.25)

Reports Q3 (Sep) earnings of $1.68 per share, excluding non-recurring items, $0.23 better than the Reuters Estimates consensus of $1.45. Co issues in-line guidance for FY07, sees EPS of $6.05-6.15 vs. $6.08 consensus.
16:21 PPDI prelim $0.32 vs $0.32 Reuters consensus; revs $357.2 mln vs $332.21 mln Reuters consensus

16:21 INFN Infinera misses by $0.07, misses on revs, but up 708% yr/yr (26.72 +1.10)

Reports Q3 (Sep) loss of $0.07 per share, $0.06 worse than the Reuters Estimates consensus of ($0.01); revenues rose 707.6% year/year and 6.6% sequentially to $62.2 mln vs the $71.7 mln consensus (3 estimates). Co says “We are pleased with Q3 results as they demonstrate growing customer acceptance of Infinera’s innovative approach to building optical networks… we made significant strides in reducing our customer concentration and further penetrating other markets.” Seven new customers were added in Q3, expanding the customer roster to 38, vs 31 in Q2.
16:21 WIRE Encore Wire misses by $0.37, misses on revs (23.15 +0.71)

Reports Q3 (Sep) earnings of $0.24 per share, $0.37 worse than the single estimate $0.61; revenues fell 17.3% year/year to $308.5 mln vs the $350 mln single estimate.
16:20 ATAC sees FY07 $1.75-$1.80 (vs $1.63 Reuters consensus), up from previous guidance of $1.55-$1.70

16:19 ATAC prelim $0.50 vs $0.37 Reuters consensus; revs $133.5 mln vs $138.88 mln Reuters consensus

16:19 CTHR Charles & Colvard misses by $0.06, misses on revs; guides FY07 revs below consensus (3.82 -0.11)

Reports Q3 (Sep) earnings of $0.01 per share, $0.06 worse than the Reuters Estimates consensus of $0.07; revenues fell 45.5% year/year to $6.6 mln vs the $10.5 mln consensus. Co issues downside guidance for FY07, sees FY07 revs of $30-33 mln vs. $36.08 mln consensus. commented, “Our results for the third quarter have not met our expectations. The factors that negatively affected the third quarter are a continuation of what has transpired in our business during the first half of the fiscal year. Moissanite customer orders continue to be slow due primarily to ongoing higher than average inventory levels among our direct manufacturing customers and at the retail level. Additionally, the economic environment for some of our domestic jewelry manufacturing customers is becoming more challenging, with increased foreign competition and consolidation within the domestic industry. We also did not experience significant sell-in revenue during the third quarter 2007 compared to $2.2 million of sell-in revenue during the third quarter last year. We have reduced our quarterly inventory purchase commitment for the fourth quarter from our leading supplier by nearly one half in order to reduce our overall inventory position.”
16:18 HLIT Harmonic beats by $0.03, beats on revs (11.57 -0.05)

Reports Q3 (Sep) earnings of $0.15 per share, $0.03 better than the Reuters Estimates consensus of $0.12; revenues rose 30.8% year/year to $82.3 mln vs the $75.3 mln consensus. The Company anticipates that the combined net sales for 4Q07 and 1Q08 will be in a range of $155 to $165 mln and gross margins will be 41% to 43% on a GAAP basis. Non-GAAP gross margins for the same period, excluding stock-based compensation expense and the amortization of intangibles, are anticipated to be in a range of 45% to 47%.
16:18 PVSW Pervasive Sftwr reports Q1 EPS of $0.05 vs $0.05 single analyst est; revs rose 2% YoY to $10.2 mln vs $10.10 mln single analyst est (4.71 +0.00)

Co also sees Q2 EPS of $0.03-0.06 vs $0.06 single analyst est; sees revs $9.5-10.5 mln vs $10.40 mln single analyst est.
16:18 ITI Iteris Holdings reports Q2 net of 0.06 vs 0.02 in the yr-ago; revs rose 17.4% to $17.0 mln (2.52 +0.02)

16:17 DFG Delphi Fin reports EPS in-line (40.58 -0.63)

Reports Q3 (Sep) earnings of $0.81 per share, excluding non-recurring items, in-line with the Reuters Estimates consensus of $0.81; co reports revs up 7.3% yr/yr to $387.2 mln.
16:16 BRCM Broadcom reports Q3 results (42.06 )

Reports Q3 (Sep) earnings of $0.27 per share, may not be comparable Reuters Estimates consensus of $0.07; revenues rose 5.3% year/year to $950 mln vs the $928.5 mln consensus. “New product cycles enabled Broadcom to attain record revenue and generate strong operating cash flow in the third quarter,” said Scott A. McGregor, Broadcom’s President and Chief Executive Officer. “Our record revenue was driven by strength in the Bluetooth, wireless LAN and digital TV markets. Broadcom continues to be a product cycle-driven company with a strong track record of successfully entering new markets. Looking forward, in the fourth quarter and in 2008 we will continue to invest aggressively in research and development of products for the very large cellular handset market, as well as new product offerings to address more of our existing customers’ needs.”
16:16 CRI prelim $0.58 vs $0.56 Reuters consensus; revs $410.9 mln vs $412.79 mln Reuters consensus

16:16 BSX Boston Scientific Carotid Artery Stenting Trials Produce positive 3 yr results (14.55 +0.25)

The co announces “positive three-year results from its CABERNET and BEACH carotid artery stenting clinical trials. The studies evaluated the effectiveness of stenting with embolic protection for patients at high risk for carotid endarterectomy, the surgical treatment for carotid artery disease.”
16:16 ALTR sees Q4 rev flat to down 4% sequentially or roughly $303.2-315.8 mln vs $335.54 mln Reuters consensus

16:16 DFG prelim $0.81 vs $0.81 Reuters consensus

16:16 NBR Nabors Ind beats by $0.04 (28.55 +0.1

Reports Q3 (Sep) earnings of $0.76 per share, $0.04 better than the Reuters Estimates consensus of $0.72.
16:15 CHRW prelim $0.48 vs $0.48 Reuters consensus; revs $1.87 bln vs $1.91 bln Reuters consensus

16:15 CAKE prelim $0.26 vs $0.27 Reuters consensus; revs $375.5 mln vs $382.82 mln Reuters consensus

16:15 ALTR prelim $0.20 vs $0.20 Reuters consensus, $0.19 First Call; revs $315.78 mln vs $324.90 mln Reuters consensus

16:15 CYMI Cymer beats by $0.06, beats on revs; sees Q4 revs +5% sequentially (42.23 +0.9

Reports Q3 (Sep) earnings of $0.65 per share, $0.06 better than the Reuters Estimates consensus of $0.59; revenues fell 8.2% year/year to $132.1 mln vs the $123.4 mln consensus. For Q4, the co says that total rev is expected to grow approx 5% sequentially, (calculates to roughly $138.72 mln) vs. $130.97 mln consensus.
16:15 CEC announces $250 Million Increase in Borrowing Capacity

16:15 RVBD Riverbed Technology reports EPS in-line, beats on revs

Reports Q3 (Sep) earnings of $0.17 per share, in-line with the Reuters Estimates consensus of $0.17; revenues rose 157.3% year/year to $63.3 mln vs the $61.4 mln consensus. “GAAP gross margins improved from 69.7% in the June quarter to a record 71.3% in the third quarter. This improvement, combined with our rapid revenue growth, led to record non-GAAP net income despite a higher tax rate and even as we rapidly added personnel and invested in our infrastructure to facilitate anticipated future growth…”
16:14 CEC announces a $200 Million Increase in Share Repurchase Authorization

16:14 MANH sees FY07 $1.29-1.34 vs $1.30 Reuters consensus

16:14 NVLS Novellus beats by $0.03, beats on revs (27.63 +0.25)

Reports Q3 (Sep) earnings of $0.41 per share, $0.03 better than the Reuters Estimates consensus of $0.38; revenues fell 11.4% year/year to $393.3 mln vs the $387.4 mln consensus. Co says “The results for Q3 were as expected. We continue to control our operating expenses during the current slowdown and to enhance our product portfolio…In addition, we continued our stock buyback program throughout the quarter, retiring approximately 5% of the outstanding shares while maintaining a very strong balance sheet. We feel while the industry is currently in a state of flux, we are well positioned for the next upturn.”
16:14 HOKU HOKU Scientific beats by $0.02, reports revs in-line (9.67 +0.29)

Reports Q2 (Sep) loss of $0.04 per share, excluding non-recurring items, $0.02 better than the Reuters Estimates consensus of ($0.06); revenues fell 87.4% year/year to $0.2 mln vs the $0.2 mln consensus.
16:14 CEC sees FY08 $2.10-2.20 vs $2.29 Reuters consensus

16:14 GSIG GSI Group announces $7 mln order and $10 mln letter of intent for advanced laser fuse M550 wafer repair processing systems (10.80 +0.14)

Co announces that an existing Taiwanese customer, has issued a $7 mln order and an additional $10 mln letter of intent for multiple M550 IR advanced laser wafer repair processing systems. Six of these systems are expected to be delivered in the fourth quarter of 2007. The remaining systems are expected to be delivered in the first half of 2008.
16:14 MANH sees Q4 $0.35-0.40 vs $0.38 Reuters consensus

16:14 JNPR Juniper Networks beats by $0.01, beats on revs (37.17 +1.2

Reports Q3 (Sep) earnings of $0.22 per share, excluding non-recurring items, $0.01 better than the Reuters Estimates consensus of $0.21; revenues rose 28.1% year/year to $735 mln vs the $707.8 mln consensus. Co reports gross margin 69.0% vs ~66.8% street expectation. CEO says, “We are pleased with both the results for the quarter and the momentum we are seeing, which reflect confidence in Juniper to address the high-performance networking requirements of our customers. Our strategy and focus on the delivery of high-performance networking, coupled with the ongoing implementation of operational discipline across the company, adds up to continuing opportunity for growth.”
16:14 CEC sees FY07 $1.98-2.02 vs $2.00 Reuters consensus

16:14 MANH prelim $0.34, ex items vs $0.32 Reuters consensus; revs $84.6 mln vs $82.27 mln Reuters consensus

16:13 FLEX Flextronics beats by $0.01, beats on revs (11.84 +0.36)

Reports Q2 (Sep) earnings of $0.24 per share, $0.01 better than the Reuters Estimates consensus of $0.23; revenues rose 18.2% year/year to $5.56 bln vs the $5.46 bln consensus.
16:13 CEC prelim $0.50 vs $0.48 Reuters consensus; revs $197.5 mln vs $196.25 mln Reuters consensus

16:13 BCR C.R. Bard beats by $0.01

Reports Q3 (Sep) earnings of $0.93 per share, excluding $0.03 non-recurring gain, $0.01 better than the Reuters Estimates consensus of $0.92; revenues rose 9.5% year/year to $544.8 mln vs the $546.4 mln consensus.
16:13 RFMD RF Micro Device beats by $0.04, beats on revs; guides Q3 EPS in-line, revs in-line (7.22 +0.09)

Reports Q2 (Sep) earnings of $0.11 per share, $0.04 better than the Reuters Estimates consensus of $0.07; revenues rose 3.6% year/year to $255.8 mln vs the $241 mln consensus. Co issues in-line guidance for Q3, sees EPS of $0.08 - $0.09 vs. $0.09 consensus; sees Q3 revs of $265 - $280 vs. $266.09 mln consensus.
16:12 HOKU sees Q3 revs $1-1.4 mln vs $0.90 mln Reuters consensus

16:12 EPIC sees FY08 $0.96-0.99 vs $1.02 Reuters consensus; sees revs $458-468 mln vs $473.64 mln Reuters consensus

16:12 MATK Martek Wins German DHA Patent Infringement Actions Against Lonza and one of Nutrinova’s customers (29.63 +0.50)

The co announces “that a three-judge panel of a district court in Dusseldorf, Germany, has orally announced a judgment in favor of Martek in the co’s patent infringement suit against (i) Lonza Ltd., (ii) Celanese Ventures GmbH and (iii) Nutrinova Nutrition Specialties & Food Ingredients GmbH. In a separate suit against Lichtwer Pharma GmbH, one of Nutrinova’s customers, a similar judgment was announced. The first suit involves Lonza’s German sale and use of a fatty acid product currently marketed under the brand name Lonza DHA for use in functional foods and dietary supplements. The second suit involves Lichtwer’s German sale and use of a DHA-containing oil in a supplement marketed under the brand name AMEU(R) Alge. The Martek patent that has been infringed is European Patent No. 0 515 460 relating to microbial oils containing at least 35% DHA (docosahexaenoic acid). The court is expected to deliver its written judgments within thirty days. The decisions may be appealed by Lonza and Lichtwer to the higher regional court in Dusseldorf.”
16:12 CTX Centex CEO says co is “meaningfully reducing prices” in response to market conditions (24.64 -0.93)

16:12 EPIC sees Q4 $0.26-0.27 vs $0.29 Reuters consensus; sees revs $110-112 mln vs $119.43 mln Reuters consensus

16:12 PLT Plantronics beats by $0.06, reports revs in-line; guides Q3 EPS in-line, revs in-line (32.61 +0.24)

Reports Q2 (Sep) earnings of $0.39 per share, excluding non-recurring items, $0.06 better than the Reuters Estimates consensus of $0.33; revenues rose 6.8% year/year to $208.2 mln vs the $209.1 mln consensus. Co issues in-line guidance for Q3 (Dec), sees EPS of $0.37-0.42, excluding non-recurring items, vs. $0.43 consensus; sees Q3 revs of $230-235 mln vs. $233.2 mln consensus.
16:11 INFN prelim GAAP ($0.07) may not be comparable to $0.00 Reuters consensus; revs $62.2 mln may not be comparable to $71.67 mln Reuters consensus

16:11 TRMB Trimble Navigation beats by $0.01, misses on revs; guides Q4 EPS in-line, revs in-line

Reports Q3 (Sep) earnings of $0.29 per share, excluding non-recurring items, $0.01 better than the Reuters Estimates consensus of $0.28; revenues rose 26.0% year/year to $296 mln vs the $299.9 mln consensus. Co issues in-line guidance for Q4, sees non-GAAP EPS of $0.24-0.26 vs. $0.25 consensus; sees Q4 revs of $295-300 mln vs. $296.01 mln consensus.
16:11 CLZR prelim $0.01 vs $0.01 Reuters consensus, $0.02 First Call; revs $35.5 mln vs $38.86 mln Reuters consensus

16:11 ILMN Illumina beats by $0.15, beats on revs; guides Q4 EPS above consensus, revs in-line

Reports Q3 (Sep) earnings of $0.34 per share, excluding non-recurring items, $0.15 better than the Reuters Estimates consensus of $0.19; revenues rose 82.2% year/year to $97.5 mln vs the $93.8 mln consensus. Co issues mixed guidance for Q4, sees EPS of $0.32-0.35 vs. $0.21 consensus; sees Q4 revs of $100-104 mln vs. $101.23 mln consensus.
16:11 EPIC prelim $0.22 vs $0.23 Reuters consensus; revs $103.1 mln vs $107.51 mln Reuters consensus

16:11 HOKU prelim ($0.04) vs ($0.06) Reuters consensus, ($0.07) First Call; revs $0.24 mln vs $0.24 mln Reuters consensus

16:11 AMZN Amazon.com beats by $0.01, beats on revs; guides Q4 revs in-line; guides FY07 revs in-line (100.83 +9.53)

Reports Q3 (Sep) earnings of $0.19 per share, $0.01 better than the Reuters Estimates consensus of $0.18; revenues rose 41.1% year/year to $3.26 bln vs the $3.13 bln consensus. AMZN reports 23.4% gross margins vs 23.6% street expectations . Co issues in-line guidance for Q4, sees Q4 revs of $5.1-5.45 bln vs. $5.14 bln consensus. Co issues in-line guidance for FY07, sees FY07 revs of $14.26-14.61 bln vs. $14.18 bln consensus.
16:10 SSTI Silicon Storage reports Q3 revs of $107.5 mln vs $105.33 mln consensus; does not report EPS due to previously announced restatement (3.71 +0.20)

Co sees Q4 revs of $100-108 mln vs $117.95 mln consensus. Co expects to report all delinquent periodic reports with the Securities and Exchange Commission by the end of 2007. However, various things could occur that could cause the co to miss that expectation.
16:09 GSIG prelim GAAP $0.18 may not be comparable to vs $0.15 Reuters consensus, $0.16 First Call; revs $84 mln vs $82.23 mln Reuters consensus

16:09 CLMS prelim $0.32 vs $0.34 Reuters consensus; revs $118.5 mln vs $120.2 mln Reuters consensus

16:08 SUPX says they are projecting Q3 to be flat sequentially due to uncertainty in near-term EL driver sales and potential seasonality dip in medical ultrasound products, although orders appear to be robust at this time

16:08 SIAL raises FY07 EPS guidance to $2.25-2.35 vs $2.28 Reuters consensus; sees organic rev growth of 7%

16:08 BCR prelim $0.93 ex $0.03 gain vs $0.92 Reuters consensus; revs $544.8 mln vs $546.38 mln Reuters consensus

16:08 SUPX prelim $0.32 vs $0.35 Reuters consensus, $0.34 First Call; revs $22.02 mln vs $21.65 mln Reuters consensus

16:08 AFL prelim $0.85 vs $0.82 Reuters consensus; revs $3.86 bln vs $3.83 bln Reuters consensus

16:07 SIAL prelim $0.54 vs $0.55 Reuters consensus; revs $503.2 mln vs $493.49 mln Reuters consensus

16:07 CSGS prelim $0.39 vs $0.37 Reuters consensus, $0.38 First Call; revs $107.60 mln vs $106.65 mln Reuters consensus

16:07 STKR Stocker Yale reports Q3 EPS of ($0.04) vs ($0.04) in yr ago period; reports revs up 75% yr/yr to $7.9 mln with no estimates (1.25 +0.01)

16:07 BRCM prelim $0.27, excl option expense, may not be comparable to vs $0.07 Reuters consensus; revs $950 mln vs $928.47 mln Reuters consensus

16:07 PFWD sees Q4 $0.15-0.16 vs $0.15 Reuters consensus; sees revs $36.0-36.8 mln vs $35.34 mln Reuters consensus

16:07 CYMI sees Q4 rev growth of 5% sequentially, roughly $138.72 mln vs $130.97 mln Reuters consensus

16:06 ROL Rollins announces 3-for-2 stock split and declares dividend (27.87 +0.27)

Co announced that the Board of Directors has approved a three-for-two stock split of the Company’s common shares. The split will be effected by issuing one additional share of common stock for every two shares of common stock held. The additional shares will be distributed on December 10, 2007, to holders of record at the close of business on November 12, 2007. Fractional share amounts resulting from the split will be paid to shareholders in cash. In addition, the co declared a regular quarterly cash dividend of $0.075 per share payable December 10, 2007 to stockholders of record at the close of business November 12, 2007. The cash dividend will be paid on the pre-split shares.
16:06 PFWD prelim $0.16 vs $0.14 Reuters consensus; revs $34.9 mln vs $33.72 mln Reuters consensus

16:06 TRMB sees Q4 $0.24-0.26 vs $0.25 Reuters consensus; sees revs $295-300 mln vs $296.01 mln Reuters consensus

16:06 ENTU sees FY07 $0.00 vs $0.00 Reuters consensus

16:06 WPP Wausau Paper reports Q3 EPS of $0.08 excluding gains vs $0.11 two analyst est; revs rose 4% YoY to $319 mln vs $322.79 mln single analyst est (10.31 +0.13)

16:06 EXEL Exelixis: Updated phase 1 data for Exelixis’ XL184 demonstrate Pharmacodynamic and clinical anti-tumor activity (11.38 +0.40) -Update-

The co announces that it “reported encouraging data from an ongoing phase 1 trial of XL184, a potent inhibitor of MET, RET, and VEGFR kinases, in patients with advanced solid tumors or lymphoma. Anti-tumor activity has been observed in a variety of cancers at doses that are not associated with significant toxicity. Consistent with the anti-VEGFR activity of XL184, preliminary pharmacodynamic analyses show reductions in several biomarkers of of angiogenesis… There were 33 patients available for safety, pharmacokinetic, and tumor response analyses as of the June 22, 2007 cutoff; further data were also provided for six additional patients after the cutoff. Of seven patients with medullary thyroid cancer, three have had partial responses (2 confirmed and 1 unconfirmed). Six of the seven patients had tumor shrinkage and one had non-measurable disease. All seven assessable patients with MTC experienced a rapid decrease in plasma levels of calcitonin, a marker frequently elevated in medullary thyroid cancer, and six of the seven patients had a decrease in the tumor marker carcinoembryonic antigen. All seven MTC patients are still on study. In addition, one patient with a neuroendocrine tumor has an unconfirmed partial response. In total, 15 patients with various solid malignancies or lymphoma have had stable disease lasting from three months to up to 20 months, including nine patients with stable disease for more than six months. “
16:06 JNPR prelim reports gross margin 69.0% vs ~66.8% street expectation

16:06 TRMB prelim $0.29 vs $0.28 Reuters consensus; revs $296 mln vs $299.90 mln Reuters consensus

16:06 NVLS prelim $0.41 vs $0.38 Reuters consensus; revs $393.3 mln vs $387.4 mln Reuters consensus

16:06 ENTU prelim $0.00 vs $0.00 Reuters consensus; revs $23.9 mln vs $25.57 mln Reuters consensus

16:05 CYMI prelim $0.65 vs $0.59 Reuters consensus; revs $132.12 mln vs $123.36 mln Reuters consensus

16:05 RVBD prelim $0.17 vs $0.17 Reuters consensus; revs $63.3 mln vs $61.44 mln Reuters consensus

16:05 FMT Fremont General Announces Significant Developments; announces Adoption of Stockholder Rights Plan to preserve use of net operating losses (3.37 +0.01)

Co announces that it has entered into a Stockholder Rights Plan under which one right will be distributed as a dividend for each share of the co’s common stock held by stockholders of record as of the close of business on November 2, 2007. The Rights Plan has been adopted as a means to assist in the preservation of the use of previously accumulated net operating losses.
16:05 JNPR prelim $0.22 vs $0.21 Reuters consensus; revs $735.0 mln vs $707.82 mln Reuters consensus

16:05 PLT sees Q3 $0.37-0.42 vs $0.43 Reuters consensus; sees revs $230-235 mln vs $233.2 mln Reuters consensus

16:04 XL prelim $3.13 ex items vs $2.38 Reuters consensus

16:04 CSCD sees Q4 ($0.02)-0.02 vs $0.05 Reuters consensus; sees revs $20-22 mln vs $23.68 mln Reuters consensus

16:04 AMZN reports 23.4% gross margins vs 23.6% street expectations

16:04 AMSG reaffirms FY07 $1.43-1.45 ex items vs $1.41 Reuters consensus; tightens revs guidance to $520-530 mln vs $524.69 mln Reuters consensus

16:03 VOCS sees Q4 $0.12 - 0.13 vs $0.13 Reuters consensus; sees revs $15.6 - $15.8 mln vs $15.59 mln Reuters consensus

16:03 CSCD prelim ($0.02) vs ($0.04) Reuters consensus; revs $21.3 mln vs $21.47 mln Reuters consensus

16:03 CTHR sees FY07 revs $30-33 mln vs $36.08 mln Reuters consensus

16:03 DDUP Data Domain Announces Intent to File Registration Statement for Underwritten Common Stock Offering (40.39 +1.44)

The co announces that “it intends to file a registration statement with the SEC for an underwritten offering of approximately 8,500,000 shares of its common stock. The shares of common stock expected to be sold in the offering will include approximately 4,000,000 shares to be sold by Data Domain and approximately 4,500,000 shares to be sold by certain existing stockholders of Data Domain. In addition, Data Domain and the selling stockholders expect to grant the underwriters of the offering an option to purchase additional shares of common stock constituting up to fifteen percent of the total number of shares offered.”
16:03 CTHR prelim $0.01 vs $0.07 Reuters consensus; revs $6.6 mln vs $10.49 mln Reuters consensus

16:02 ATEC Alphatec reports Q3 net loss of ($0.04), up YoY from a loss of ($0.13); revs rose 17% YoY to $20.31 mln (4.27 +0.07)

16:02 FLEX prelim $0.24 vs $0.23 Reuters consensus; revs $5.56 bln vs $5.46 bln Reuters consensus

16:02 ILMN sees Q4 $0.32-0.35 vs $0.21 Reuters consensus; sees revs $100-104 mln vs $101.23 mln Reuters consensus

16:02 HLIT sees Q4 and Q1 revs of $155-165 mln vs $156.65 mln consensus

16:01 ILMN prelim $0.34 vs $0.19 Reuters consensus; revs $97.5 mln vs $93.79 mln Reuters consensus

16:01 AMSG sees Q4 $0.36-0.38 vs $0.37 Reuters consensus

16:01 AMZN sees Q4 revs $5.1-5.45 bln vs $5.14 bln Reuters consensus

16:01 RFMD sees Q3 $0.08-0.09 vs $0.09 Reuters consensus; sees revs $265-280 mln vs $266.09 mln Reuters consensus

16:01 PLT prelim $0.34 vs $0.33 Reuters consensus; revs $208.2 mln vs $209.13 mln Reuters consensus

16:01 AMZN prelim $0.19 vs $0.18 Reuters consensus; revs $3.26 bln vs $3.13 bln Reuters consensus

16:01 NBR prelim $0.76 vs $0.72 Reuters consensus, $0.73 First Call; revs ${REV} vs $1.18 bln Reuters consensus

16:01 KOSN Kosan Biosciences presents phase 1 data showing antitumor activity and safety profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting (6.08 +0.29)

Co presented updated data from a Phase 1 clinical trial showing that KOS-1584/R1645, an epothilone under co-development with Roche, demonstrated antitumor activity and tolerability in patients with solid tumors. KOS-1584/R1645 showed signs of activity in patients with non-small cell lung, ovarian, breast, prostate, pancreatic, head and neck and colon cancer. The Phase 1 trial explored two different schedules of KOS-1584/R1645 using escalating doses. Data reported today were from a trial investigating weekly dosing schedules (weekly 2 weeks out of 3 weeks and weekly 3 weeks out of 4 weeks). Common toxicities were generally low-grade and manageable. Co says they believe that KOS-1584 has the potential to achieve best-in-class status in the emerging epothilone market as well as to compete in the established taxane market. They look forward to our planned commencement of a Phase 2 clinical program for KOS-1584 toward the end of 2007.
16:01 ATRM prelim $0.13 vs $0.10 Reuters consensus; revs $7.70 mln vs $6.90 mln Reuters consensus

16:01 RFMD prelim $0.07 vs $0.07 Reuters consensus; revs $255.8 mln vs $241.03 mln Reuters consensus

16:01 EPIQ prelim $0.13 vs $0.13 Reuters consensus, $0.14 First Call; revs $39.2 mln vs $41.35 mln Reuters consensus, $44.35 mln First Call

16:00 AMSG prelim $0.35 vs $0.35 Reuters consensus; revs $132.1 mln vs $129.93 mln Reuters consensus

16:00 HLIT prelim $0.15 vs $0.12 Reuters consensus; revs $82.3 mln vs $75.34 mln Reuters consensus

16:00 VSEC VSE Increases Support Services Under U.S. Army Rapid (56.41 +1.06)

The co announces “that its Rapid Response Support Contract task order awards for last month increased by approximately by $180.4 mln. The new task orders and expanded level of effort requirements require program mgmt, systems engineering, integrated logistics, and technical services in support of various U.S. Army and U.S. Navy activities at multiple locations.”
16:00 WIRE prelim $0.24 vs $0.61 Reuters consensus; revs $308.5 mln vs $350.00 mln Reuters consensus

Half a Person

Recipe for Success

ASSISTANT CLAIMS WIFE KILLED CIRCLE T PARTNERS FOUNDER

Sam Zell on Risk Mgmt

Using Inside Information

Weis and New Irish Recruits Kobayashi and Eater X Vow to Eat All Evidence of 2007 Season!

No Free Lunch: Ongoing Ramifications of an Easy Fed

More Homeowners Filing Bankruptcy to Halt Foreclosure

Chicago builder, Neumann Homes, closes branches, prepares bankruptcy filing

Socrates, Stocks, and Self-Advice

They sucked em in with the slow overnite grind to the right sell spots on the 30 minute charts when it comes to the futures. Then Wal Mart hits the market with its lower capital expenditures speak @ 8 am and down we go. They are finding some support down at the ORB range from yesterday @ 1510, see if they can rally here or fall to the next line near 1502.

07:48 UPS UPS beats by $0.03, reports revs in-line; guides FY07 EPS in-line (75.09 )

Reports Q3 (Sep) earnings of $1.05 per share, excluding non-recurring items, $0.03 better than the Reuters Estimates consensus of $1.02; revenues rose 4.7% year/year to $12.21 bln vs the $12.24 bln consensus. Co issues in-line guidance for FY07, sees EPS of $4.13-4.19 vs. $4.15 consensus.
07:48 ZRAN Zoran: Beats expectations again - Montgomery (20.86 )

Montgomery raises their ests and tgt on ZRAN to $26 following the release of strong 3Q7 resulst last night. Firm notes ZRAN continues to benefit from strength across all segments, reporting record revs from DTV and Printer Imaging and seasonal strength from DVD. Firm believes ZRAN remains well positioned for continued success and is on track to gain market share across each product line.
07:47 TRAD TradeStation beats by $0.02, beats on revs; guides Q4 EPS in-line, revs in-line (11.94 )

Reports Q3 (Sep) earnings of $0.22 per share, $0.02 better than the Reuters Estimates consensus of $0.20; revenues rose 25.0% year/year to $40.3 mln vs the $39.2 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.19-0.21 vs. $0.21 consensus; sees Q4 revs of $37-40 mln vs. $38.5 mln consensus.
07:47 CRNT Ceragon: Solid execution results in 3Q that is well above ests; co raises top line outlook but maintains operating margin goal at 10% for 2H 2008 - Susquehanna (19.84 )

07:47 EAT prelim $0.35 vs $0.40 Reuters consensus; revs $895.08 mln vs $1.07 bln Reuters consensus

07:46 MRTN Marten Transport: Hearing downgraded to Equal Weight at boutique firm (15.40 )

07:46 TXN Texas Instruments: Color on quarter (34.27 )

ThinkEquity notes TXN reported Q3 results above consensus with revs and EPS of $3.663 bln and $0.54 (consensus $3.659 bln and $0.50). Firm notes mgmt guided wireless revs flat for Q4 due to customer pull-in’s and increasing competition at Ericsson. Firm cuts their rev ests for 4Q07 to $3.54 bln from $3.7 bln and CY07 to $13.82 bln from $13.97 bln. Firm cuts their tgt to $31 from $33… Thomas Weisel believes lower rev is expected due to due to higher mix of low end handsets, inventory conscious OEMs and market share losses. Firm believes these are short-term issues and expect continued market share gains in HPA will continue to drive gross margin higher through 2008. Firm believes this lower rev outlook could be attributed to some order pull-ins from 4Q to meet 3Q demand, the inventory conscious handset inventory supply chain trying to keep inventory tight going into 1Q08 as well as some market share loss at Ericsson. While they recognize TXN will see a pause near-term, the pause is likely to be temporary. Furthermore, low supply chain inventory may soften the q/q decline in the seasonally weak 1Q08… Other analyst calls: J.P Morgan downgraded TXN to Neutral from Overweight … UBS downgraded TXN to Neutral from Buy and lowers their tgt to $38 from $44… Jefferies downgrades TXN to Hold from Buy and cut their tgt to $37 from $43.
07:46 UPS sees FY07 $4.13-4.19 vs $4.15 Reuters consensus

07:45 YHOO Yahoo! transfered coverage with an Accumulate at ThinkEquity- tgt raised to $32 from $27 (29.83 )

ThinkEquity transferes coverage of YHOO and maintains their Accumulate rating and raises their tgt to $32 from $27 saying they believe that Yahoo! has an impressive set of online assets, including 500 mln users globally, but they believe it may take longer than expected to work through near-term challenges: declining marginal profitability, key employee turnover, slowing user growth in key verticals, competitive pressure in display media, and the risk of losing broadband partners next year. The firm says they would become more constructive on YHOO in the mid-$20 range.
07:45 JBLU prelim $0.12 vs $0.07 Reuters consensus; revs $765.0 mln vs $762.74 mln Reuters consensus

07:45 UPS prelim $1.05 vs $1.02 Reuters consensus; revs $12.21 bln vs $12.24 bln Reuters consensus

07:45 PTEC Phoenix Tech beats by $0.07, beats on revs (9.38 )

Reports Q4 (Sep) earnings of $0.10 per share, excluding non-recurring items, $0.07 better than the Reuters Estimates consensus of $0.03; revenues rose 24.6% year/year to $15.7 mln vs the $15.4 mln consensus. Co says they are now completely focused on building long term growth in revs and profitability, and are still intent on achieving our announced target of a market capitalization of a bln dollars or more within the next four years.
07:44 MICC Millicom reports Q3 (Sep) results, beats on revs (86.71 )

Reports Q3 (Sep) earnings of $1.36 per share, may not be comparable to the Reuters Estimates consensus of $0.95; revenues rose 76.8% year/year to $686 mln vs the $662.8 mln consensus. “The most encouraging aspect of these results has been in Africa where we have taken the opportunity to increase the pace of our build-out through a substantial increase in capex. This steadily increasing level of investment is driving the rate of subscriber acquisition in Africa which was up 44% year on year, up an impressive 17% quarter on quarter and delivering year on year revenue growth for the quarter of 52%. In order to exploit the growth opportunity in our African markets we have accepted a somewhat lower margin of 28% in the third quarter, but we still believe that margins will move back to historical levels whilst we continue to invest as we build critical scale.”
07:43 TRAD sees Q4 $0.19-0.21 vs $0.21 Reuters consensus; sees revs $37-40 mln vs $38.5 mln Reuters consensus

07:42 GOOG Google coverage transfered with a Buy at ThinkEquity- tgt raised to $800 from $700 (651.00 )

ThinkEquity transferes coverage of GOOG and maintains their Buy and raises their tgt to $800 from $700 as Google continues to capture market share and drive revenue growth in its core search business while investing aggressively in new growth opportunities like display, video, mobile, and traditional media. The firm says near-term catalysts include the recent east-to-north algorithm change, which they believe could drive an incremental $2 of EPS above their 2008 estimate.
07:42 LMT Lockheed Martin beats by $0.16, beats on revs; raises FY07 EPS guidance, still below consensus, reaffirms FY07 rev guidance (107.24 )

Reports Q3 (Sep) earnings of $1.80 per share, $0.16 better than the Reuters Estimates consensus of $1.64; revenues rose 15.6% year/year to $11.1 bln vs the $10.39 bln consensus. Co raises FY07 EPS guidance to $6.70-6.85 vs. $6.86 consensus; reaffirms FY07 revs of $41-41.75 bln vs. $41.7 bln consensus. Co issues downside guidance for FY08, sees EPS of $6.95-7.15 vs. $7.23 consensus; sees FY08 revs of $41.25-42.75 bln vs. $42.86 bln consensus.
07:42 T AT&T reports EPS in-line, revs in-line (41.17 )

Reports Q3 (Sep) earnings of $0.71 per share, in-line with the Reuters Estimates consensus of $0.71; revenues rose 92.5% year/year to $30.1 bln vs the $30.09 bln consensus. Co reports 2.0 million net gain in wireless subscribers; 126,000 U-verse TV subscribers in service, up from 51,000 three months earlier; total video subscribers, including satellite and AT&T U-verse, up 215,000 in the third quarter to reach 2.1 million.
07:42 TRAD prelim $0.22 vs $0.20 Reuters consensus; revs $40.3 mln vs $39.2 mln Reuters consensus

07:42 AXE Anixter beats by $0.01, reports revs in-line, sees seasonal decline in Q4 (82.55 )

Reports Q3 (Sep) earnings of $1.51 per share, $0.01 better than the Reuters Estimates consensus of $1.50; revenues rose 14.3% year/year to $1.52 bln vs the $1.52 bln consensus. CEO comments on outlook, “Assuming no significant deterioration in the economy during the final months of 2007, we will again have a record-setting year for sales, earnings and return on equity. That said, we do expect that fourth quarter sales and earnings, consistent with historical patterns for the fourth quarter, will show a modest decline from the results we reported for the recently completed third quarter. This projected decline is exclusively based on the fact that there are fewer working days in the fourth quarter due to the Thanksgiving and Christmas holidays.”
07:41 ALNY Alnylam Pharmaceuticals target raised to $37 at Rodman & Renshaw (31.26 )

Rodman & Renshaw raises their tgt on ALNY to $37 from $30, as they believe that positive data recently presented at DALM serve to de-risk ALNY’s current PCSK9 RNAi therapeutic program.
07:41 CMCO Columbus McKinnon beats by $0.07, beats on revs (25.72 )

Reports Q2 (Sep) earnings of $0.54 per share, $0.07 better than the Reuters Estimates consensus of $0.47; revenues rose 5.0% year/year to $151.4 mln vs the $149.2 mln consensus.
07:40 AIZ Assurant upgraded to Buy at Keybanc- tgt $65 (56.33 )

KeyBanc upgrades AIZ to Buy from Hold and sets a $65 tgt, as they believe the recent spike of the foreclosure activity in Q307 may have a positive impact on AIZ’s Specialty Property earnings.
07:40 BIIB Biogen Idec misses by $0.06, misses on revs; reaffirms FY07 EPS guidance, revs guidance (80.11 )

Reports Q3 (Sep) earnings of $0.58 per share, excluding non-recurring items, $0.06 worse than the Reuters Estimates consensus of $0.64; revenues rose 12.2% year/year to $789 mln vs the $802.4 mln consensus. Co reaffirms guidance for FY07, sees EPS of $2.60-2.70 vs. $2.66 consensus; sees FY07 revs up 16-18% yr/yr, which equates to $2.95-3.11 bln vs. $3.13 bln consensus. Co reports Avonex revs of $455 mln vs $463 mln street expectation, Rituxan revs of $235 mln vs $237 mln street expectation, and Tysabri revs of $93 mln vs $72 mln street expectation.
07:40 AXE Anixter beats by $0.01, reports revs in-line (82.55 )

Reports Q3 (Sep) earnings of $1.51 per share, $0.01 better than the Reuters Estimates consensus of $1.50; revenues rose 14.4% year/year to $1.52 bln vs the $1.52 bln consensus. “Assuming no significant deterioration in the economy during the final months of 2007, we will again have a record-setting year for sales, earnings and return on equity. That said, we do expect that fourth quarter sales and earnings, consistent with historical patterns for the fourth quarter, will show a modest decline from the results we reported for the recently completed third quarter. This projected decline is exclusively based on the fact that there are fewer working days in the fourth quarter due to the Thanksgiving and Christmas holidays.”
07:39 KELYA Kelly Services beats by $0.02, reports revs in-line; guides Q4 EPS in-line (20.81 )

Reports Q3 (Sep) earnings of $0.45 per share, excluding non-recurring items, $0.02 better than the Reuters Estimates consensus of $0.43; revenues rose 2.0% year/year to $1.43 bln vs the $1.44 bln consensus. Co issues in-line guidance for Q4, sees EPS of $0.46-0.51 vs. $0.49 consensus.
07:39 UAUA UAL Corp. beats by $0.08, misses on revs (48.13 )

Reports Q3 (Sep) earnings of $1.96 per share, excluding non-recurring items, $0.08 better than the Reuters Estimates consensus of $1.88; revenues rose 6.8% year/year to $5.5 mln vs the $5413.1 mln consensus. Including the effects of cost savings initiatives previously announced, the company estimates that mainline CASM excluding fuel and special items will increase by 6.0-6.5% for Q4 versus the comparable period of 2006. Approximately half of the y/y increase is driven by higher maintenance costs due to increased heavy maintenance volumes and rate increases in some of our outsourcing contracts. Another 1 point of the increase is due to lower operating expenses in 4Q06 from two favorable insurance settlements. In addition, higher profit sharing expense is causing 1 point of the y/y increase. Co expects 2007 full-year CASM excluding fuel, severance and special items to increase by ~2.5%. UAUA expects mainline jet fuel price per gallon, including the impact of hedges, to average $2.50 per gallon in Q4.
07:39 RCKY Rocky Brands misses Q3 ests; issues downside FY07 EPS guidance, in line rev guidance (9.28 )

RCKY reports Q3 EPS of $0.21 vs $0.91 Reuters consensus; revs rose 5% YoY to $82.3 mln vs $83.33 mln Reuters consensus. RCKY sees FY07 $0.30 vs $1.11 Reuters consensus, down from previous guidance of approximately $1.16; sees revs $280.00 mln vs $280.53 mln Reuters consensus. “While our third quarter sales were in-line with our projections our earnings were lower than we anticipated due to a combination of factors. During the quarter we experienced a 550 basis point decline in gross margin as a result of significant pricing pressure and an increase in product costs. In addition, we made the strategic decision to increase our retail operating expenses in order to capitalize on the near-term prospects created by the bankruptcy of a key competitor. We are committed to driving further top-line gains in both our wholesale and retail divisions while at the same time evaluating all our opportunities in an effort to return to more normalized margins beginning in 2008.”
07:39 AAPL Apple upgraded to Buy at ThinkEquity- tgt raised to $227 from $164 (174.36 ) -Update-

ThinkEquity upgrades AAPL to Buy from Accumulate and raises their tgt to $227 from $164 following earnings and saying with a refresh of its Mac and iPod lineups, and three new carriers set to debut iPhone in Europe in November, they believe Apple will continue to outpace the industry in growth heading into the holiday season.
07:38 FMER FirstMerit Corp beats by $0.01 (18.57 )

Reports Q3 (Sep) earnings of $0.38 per share, $0.01 better than the Reuters Estimates consensus of $0.37. “Our primary goal is to generate increased returns and build long-term shareholder value at FirstMerit. One of our main objectives in the near-term is to continue the solid momentum that we have established in improving and maintaining asset quality. We believe we will achieve this by executing on our enhanced underwriting and portfolio management procedures”.
07:38 T prelim $0.71 vs $0.71 Reuters consensus; revs $30.1 bln vs $30.09 bln Reuters consensus

07:37 TROW T. Rowe Price reports EPS in-line, misses on revs (54.69 )

Reports Q3 (Sep) earnings of $0.63 per share, in-line with the Reuters Estimates consensus of $0.63; revenues rose 26.7% year/year to $571 mln vs the $578.5 mln consensus. Co said, “Looking ahead, despite the recent market turmoil, we remain optimistic about the prospects for stocks over the longer term. We believe that the global economy will continue to grow at a reasonable rate and that the weakness in U.S. housing will continue to work its way through the system. Companies producing stable earnings growth will be afforded higher prices. In our view, this environment should favor our focus on selecting stocks with sound fundamentals and attractive valuations.”
07:37 WU Western Union beats by $0.02, reports revs in-line; guides FY07 EPS above consensus (18.98 )

Reports Q3 (Sep) earnings of $0.30 per share, excluding $0.02 per share non-cash charge for the acceleration of stock compensation expense related to the acquisition of First Data by KKR, $0.02 better than the Reuters Estimates consensus of $0.28; revenues rose 10.2% year/year to $1.26 bln vs the $1.26 bln consensus. Co issues upside guidance for FY07, sees EPS of $1.11-1.13, excluding non-recurring items, vs. $1.08 consensus; co sees Y07 GAAP revs up 10%.
07:37 VNBC Vineyard Natl downgraded to Neutral from Buy at Oppenheimer (16.24 )

07:37 TRAD TradeStation reports metrics of $1.7 bln in assets on 80.859 daily avg trades for month ended Sept 30 (11.94 +0.14)

reported the following business metrics for the month ended September 30, 2007: 80,589 Daily Average Revenue Trades; Total client assets of $1.7 bln (as of September 30, 2007); Average equities client credit balances of $553 million; Average equities client margin balances of $84 mln YoYr, TradeStation’s DARTs increased 34%, total client assets increased 10%, average equities client credit balances increased 5%, and average equities client margin balances increased 35%.
07:37 AMTD TD Ameritrade beats by $0.02, beats on revs; guides FY08 EPS in-line (19.12 )

Reports Q4 (Sep) earnings of $0.33 per share, $0.02 better than the Reuters Estimates consensus of $0.31; revenues rose 17.7% year/year to $575.2 mln vs the $557.2 mln consensus. Co issues in-line guidance for FY08, sees EPS of $1.15-1.39 vs. $1.28 consensus. CEO Moglia comments, “In 2007 we successfully completed the largest client integration in the history of our industry and continued the implementation of our client segmentation strategy. Over 80 percent of our revenue growth this year was asset-based, and we plan to take that momentum into 2008″.
07:36 KELYA sees Q4 $0.46-0.51 vs $0.49 Reuters consensus

07:36 MNRO Monro Muffler beats by $0.01, reports revs in-line; guides Q3 EPS above consensus; guides FY08 EPS in-line, revs in-line (22.76 )

Reports Q2 (Sep) earnings of $0.29 per share, $0.01 better than the Reuters Estimates consensus of $0.28; revenues rose 4.4% year/year to $112 mln vs the $111.8 mln consensus. Co issues upside guidance for Q3, sees EPS of $0.27-0.29, excluding non-recurring items, vs. $0.25 consensus. Co issues in-line guidance for FY08, sees EPS of $1.08-1.11 vs. $1.10 consensus; sees FY08 revs of $440-445 mln vs. $447.08 mln consensus.
07:35 KELYA prelim $0.45, ex-items, vs $0.43 Reuters consensus; revs $1.43 bln vs $1.44 bln Reuters consensus

07:35 NFLX Netflix: Color on quarter (23.01 )

Broadpoint Capital notes NFLX reported Q3 rev and GAAP EPS of $294 mln and $0.23 vs. their ests of $283.8 mln and $0.15, respectively. Firm’s 2007 rev and EPS ests go to $1.21 bln and $0.85 from $1.18 bln and $0.67, respectively. Their 2008 rev increases to $1.25 bln from $1.11 bln and EPS increase to $0.86 from $0.33. Firm says to keep an eye on net subscriber additions, down 42% annually, not gross additions, which were flattish. Firm sees nagging trends underneath the “beat-and-raise” headline NFLX offered yesterday. They also think the cult of NFLX bears is likely to push down the rally certain to follow yesterday’s strong results… Cantor notes NFLX posted stronger-than-expected 3Q07 results and offered a bullish outlook for 4Q07 and 2008. Competitive forces continue to inhibit NFLX’s growth/profit potential, but seem to be doing so less substantively than had been anticipated… Thomas Weisel notes NFLX Q3 results indicate their bullish thesis on NFLX is playing out faster and stronger than they had expected. The co reported better than expected 3Q results across the board: more new subscribers, lower churn, lower SAC, lower content costs, higher margins and better than expected EPS. Management increased its guidance for ending subs and EPS for 2007 as well as its outlook on net income for 2008. Firm increases their 2007 and 2008 subscriber, revenue and EPS estimates as well as increasing our 12-month price target to $30 from $21 per share. Firm increases 2007 rev est to $1.201 bln from $1.186 bln and EPS to $0.80 from $0.64. Firm also increases 2007 ending subscriber number assumption from 7.344 mln to 7.524 mln.
07:34 FMER prelim $0.38 vs $0.37 Reuters consensus

07:34 FCX Freeport-McMoRan: Hearing tgt raised to $135 from $130 at tier 1 firm (106.73 )

07:33 PTEC prelim $0.10 vs $0.03 single estimate; revs $155.7 mln vs $15.40 mln single estimate

07:33 LMT sees FY08 $6.95-7.15 vs $7.23 Reuters consensus; sees revs $41.25-42.75 bln vs $42.86 bln Reuters consensus

07:32 UAUA prelim $1.96 vs $1.88 Reuters consensus; revs $5.527 mln vs $5.41 bln Reuters consensus

07:32 MTLK prelim ($0.24) vs ($0.25) Reuters consensus; revs $3.9 mln vs $2.95 mln Reuters consensus

07:32 CMCO prelim $0.54 ex-items vs $0.47 Reuters consensus; revs $151.40 mln vs $149.17 mln Reuters consensus

07:32 LMT raises FY07 EPS guidance to $6.70-6.85 vs $6.86 Reuters consensus; reaffirms revs $41-41.75 bln vs $41.70 bln Reuters consensus

07:32 GFI Gold Fields: Hearing upgraded to buy from neutral at tier 1 firm (17.55 )

07:32 TROW prelim $0.63 vs $0.63 Reuters consensus; revs $571 mln vs $578.47 mln Reuters consensus

07:31 CMCO prelim $0.49 vs $0.47 Reuters consensus; revs $151.4 mln vs $149.17 mln Reuters consensus

07:31 OREX Orexigen Therapeutics reports preclinical results showing contrave acts on specific pathways in the brain to reduce food intake (15.56 )

Co presented the results of a preclinical study that further supports the co’s understanding of an aspect of the mechanism of action of Contrave, one of its two late-stage obesity drug candidates. The findings showed: The combination of bupropion and naltrexone resulted in a 94% reduction of food intake in obese mice, greater than either drug alone; The drugs act in a part of the brain where food reward pathways are located; and the combination directly increased firing of neurons associated with reduction in food intake and satiety. “We originally theorized that the combination of bupropion and naltrexone, the components of Contrave, would stimulate proopiomelanocortin (POMC) neuronal firing which would lead to sustained weight loss. These new findings indicate that Contrave may also modulate food cravings through its effect on reward pathways,” said OREX founder and Chief Scientific Officer, Michael Cowley. “We believe this aspect of Contrave’s mechanism of action may have the potential to differentiate it from other pharmaceutical therapies available or in development for the treatment of obesity.”
07:31 MNRO sees Q3 $0.27-0.29, ex items vs $0.25 Reuters consensus

07:31 AXE prelim $1.51 vs $1.50 Reuters consensus; revs $1.52 bln vs $1.52 bln Reuters consensus

07:31 AMTD sees FY08 $1.15-1.39 vs $1.28 Reuters consensus

07:31 AMSC Am Superconductor receives 150 MVAR Static VAR Compensator order (26.67 +0.86)

Co announces that it has received a multi-million-dollar order from a major U.S. utility for AMSC’s Static VAR Compensator solution. The complete turnkey solution is scheduled to be commissioned in mid-2008 and will provide 150 mega volt-ampere-reactive (MVAR) of support to help control and stabilize voltage in the utility’s surrounding power grid.
07:31 CALLS Early Research Calls VI

Upgrades: ThinkEquity upgrades Arris Group (ARRS 11.65) to Buy from Accumulate with a $15 tgt saying believe the co will make a powerful case for continued market share strength across the board and outline how it will close the C-COR transaction and achieve synergies. The firm also believes there are very low expectations going into the 3Q report, which means a favorable risk/reward at this point. Downgrades: ThinkEquity transfers coverage and downgrades ValueClick (VCLK 25.46) to Source of Funds from Buy and cuts their tgt to $22 from $34 saying they believe VCLK faces additional risk from the F.T.C inquiry into promotional activities, and that VCLK’s display network is increasingly vulnerable given the focus of market leaders on the non-premium display opportunity… Thomas Weisel downgrades Volterra Semi (VLTR 13.15) to Market Weight from Overweight following earnings, and based on lack of near term growth catalysts… UBS downgrades Zions Bancorp (ZION 61.36) to Neutral from Buy. Miscellaneous: Morgan Stanley initiates Agrium (AGU 54.42) and Potash (POT 107.1 with Underweights… Morgan Stanley initiates Mosaic (MOS 60.90) with an Equal Weight… Thomas Weisel initiates Itron (ITRI 101.11) with a Market Weight… Credit Suisse initiates Camden Property (CPT 58.56) with a Neutral… Nollenberger initiates Netgear (NTGR 30.21) with a Buy and a $36 tgt saying they believe the co offers investors a pure-play opportunity to capitalize on the global penetration of broadband connectivity, especially in emerging economies; the secular adoption of networking technologies by smaller companies; and the penetration of home networks, particularly in more established economies.
07:31 AAPL Apple: Color on quarter (174.36 )

Cross Research notes AAPL report strong 4Q7 results, which beat t